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Burkholderia contaminans MS14 shows excellent antimicrobial activities against
a wide range of pathogens. Complete sequence analysis reveals that the MS14 genome
harbors multiple gene loci that contribute to its antimicrobial activities and lacks key
virulence features commonly found in pathogenic Burkholderia species. A mutagenesis
study identified the genes required for MS14 antibacterial activities and gene expression
profiling targeted a polyketide synthase (PKS) gene cluster. Site-specific mutagenesis
confirmed the PKS gene cluster is directly related to MS14 antibacterial activities and the
PKS gene product is predicted to be the MS14 antibacterial compound.
Strain UFB2 isolated from Mississippi shows significant antifungal and
antibacterial activities. UFB2 was classified to be Pseudomonas chlororaphis and its
complete genome sequence was reported in this study. Green house trails showed P.
chlororaphis strain UFB2 could efficiently reduce the disease severity of bacterial canker
of tomato, by significantly inhibiting the growth of the pathogen Clavibacter
michiganensis subsp. michiganensis.

The research findings of B. contaminans MS14 and P. chlororaphis UFB2 have
provided insights into the development of MS14 antibacterial compound for agricultural
application and potential use of strain UFB2 as a biocontrol agent.
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COMPARATIVE GENOME-WIDE ANALYSIS REVEALS THAT BURKHOLDERIA
CONTAMINANS MS14 POSSESSES MULTIPLE ANTIMICROBIAL
BIOSYNTHESIS GENES BUT NOT MAJOR GENETIC
LOCI REQUIRED FOR PATHOGENESIS
Introduction
Burkholderia is a Gram-negative, rod-shaped, motile and non-spore-forming
bacterium that has been identified in many diverse ecological niches [1]. Currently, 88
species have been recognized in the genus Burkholderia [2]. The ecological versatility of
these bacteria is likely due to their unusually large genomes, which are often comprised
of one or multiple large replicons with plasmids [3]. The bacteria have the ability to use a
large array of carbon sources to synthesize secondary metabolites [4, 5].
Most Burkholderia species isolated from soil are associated with plants. Some
species are related to the promotion of plant growth and are considered to be plant
growth-promoting bacteria (PGPB). For example, B. phenoliruptrix and B. phymatum are
effective in nitrogen fixing [6, 7], while B. phytofirmans induces larger root systems [8].
Interests in the use of Burkholderia species or their secondary metabolites in agriculture
have increased. For example, the use of Burkholderia cepacia AMMDR1 could yield as
efficient control of “damping-off” disease caused by Pythium species and Rhizoctonia
solani as that of the fungicide Captan [4, 9]. The relatively large Burkholderia genome
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harbors a large variety of antimicrobial biosynthesis genes. Occidiofungin [10, 11]
produced by B. contaminans MS14 has significant antifungal activity. Pyrrolnitrin [5]
was first identified as an antifungal antibiotic produced by Pseudomonas species and later
found to be synthesized by several Burkholderia cepacia species. Pyoluteorin [12] and
lipopeptide AFC-BC11 [13] are other antibiotics produced by Burkholderia.
Siderophores are bacteriostatic agents that can inhibit pathogenic microorganism’s
growth by depleting iron in the soil [14]. Pyochelin [15] and ornibactin [16] are common
siderophores produced by Burkholderia species. On the other hand, plant-pathogenic
species of Burkholderia have also been identified, such as B. gladioli and B. glumae,
which infect rice and other horticultural plants [17, 18]. The commonly produced planttoxic secondary metabolites by Burkholderia species include polysaccharides and other
toxins, such as rice grain rot and wilt causal agent toxoflavin [19] and exopolysaccharide
toxin cepacian [20] that contribute to the overall pathogenicity and success of the
bacterium as a plant pathogen.
The potent antifungal occidiofungin was first identified from B. contaminans
MS14 [10]. Burkholderia contaminans MS14 was isolated from soil in Mississippi, it has
a broad range of antifungal activities to plant and human pathogens by producing an
oligopeptide occidiofungin [21]. It is a novel fungicide that can significantly inhibits the
growth of pathogens by interfering with cell wall synthesis or triggering apoptosis [11, 22,
23]. Genetically, the whole length of the ocf gene cluster required for production of
occidiofungin has been characterized, which is composed of 16 ORFs [24]. Among the
16 members of this cluster, ocfD, ocfE, ocfF, ocfH and ocfJ were predicted to encode
nonribosomal peptide synthesis (NRPS) or NRPS-polyketide synthase (PKS), which are
2

directly related to the biosynthesis of the antifungal compound occidiofungin. The genes
ocfA, ocfC, ocfK, ocfL, ocfM, and ocfN were predicted to be involved in the secretion and
modification of occidiofungin.
Burkholderia cepacia complex (Bcc) is a group of Burkholderia species that some
are opportunistic bacteria and could cause lung disease in immunocompromised
individuals [25]. The Bcc group composed of 9 different genomovars and at least 18
different species. These species include B. cepacia, B. cenocepacia, B. multivorans, B.
vietnamiensis, B. stabilis, B. ambifaria, B. dolosa, B. anthina and B. pyrrocinia [26]. B.
cepacia is a common environmental species but is also an important human pathogen
which can create respiratory complications for cystic fibrosis (CF) patients [25]. B.
cenocepacia is a major CF pathogen and is responsible for 70% of the cases of Bcc
infection [25]. B. multivorans is the second most common Bcc species in CF infection
[27], and some species like B. dolosa strains are frequently isolated from the CF patents
[28]. Bcc infections contribute to the overall poor health of CF patients [27]. It is
important to be able to distinguish virulent Bcc species, as well as some other reported
virulent Burkholderia species such as B. pseudomallei, from the less virulent soil-isolated
Burkholderia species.
Resistance to multiple antibiotics and disinfectants is very common among
Burkholderia species. This antibiotic resistance feature makes them hard to treat and is
crucial for human pathogenicity of Bcc species. There are several mechanism that
contributes to antibiotic resistance of the Bcc strains. First, efflux pumps are responsible
for exclusion of antibiotics from the cell. Secondly, some Burkholderia species could
significantly lower antimicrobial susceptibility by forming biofilm [29] or by entering a
3

non-replicating state [30]. In addition, enzymatic inactivation of antibiotics either by
modification or cleavage is a common resistance mechanism found in Burkholderia
species [31].
Several well documented bacterial virulent features for mammalian pathogenesis
are found in Burkholderia species. Cable pili and the 22-kilodalton (KDa) adhesin are
virulence factors associated with cepacia syndrome. These are required for Burkholderia
cenocepacia to bind and cross the squamous epithelium leading to an intensified chronic
infection [32]. The periplasmic located superoxide dismutase (SOD) protects bacteria
from oxidation by exogenously generated superoxide or peroxide [33]. A 31.7 kb
Burkholderia cepacia virulence genomic island (GIs) has been identified to harbor
Burkholderia cepacia epidemic strain marker (BCESM) and possesses both virulence and
metabolism-associated genes [34]. VgrG-5 is a Burkholderia type VI secretion system 5
associated protein, which is required for the full virulence of type VI secretion system 5
to induce multinucleate giant cell formation and full mammalian virulence [35].
In this study, we analyzed the phylogenetic relatedness of MS14 to seventeen
other Burkholderia species including plant pathogen, cystic fibrosis opportunistic, plant
growth-promoting strains and other soil isolates. Being able to distinguish between safe
environmental isolates of Burkholderia from a human pathogen is a current problem [36].
Our analyses provide a whole genome approach to identify less virulent environmental
isolates by comparing antibiotic biosynthesis, antibiotic resistance, and virulence loci
among Burkholderia species. The results provide important information for evaluating
Burkholderia species virulence according to their secondary metabolites production and
virulence markers.
4

Materials and Methods
Genome sequencing of B. contaminans MS14
B. contaminans MS14 was cultured in nutrient-broth yeast (NBY) extract medium
[37] overnight in a shaker at 28oC. The genomic DNA was extracted using the Wizard
Genomic DNA Purification Kit (Promega Corporation, Madison, WI, USA) and was used
for library construction with Illumina Genomic DNA Sample Preparation Kit (Illumina,
CA, USA). Twelve standard libraries (with an average insert size of 400~700 bp) and one
mate pair library (with an average insert size of 7,000 bp) were prepared and sequenced
on the Illumina MiSeq and HiSeq instrument according to the manufacturer’s instructions.
The genome was de novo assembled similar as described by Tim Durfee, etc. [38] using
DNAStar Seqman NGen (Version 12, DNASTAR, Inc. Madison, WI U.S.). Briefly, a
standard 400 bp insertion library and the mate pair library were selected as the input data
for the assembling. 40 million short reads were scanned and extracted from the raw data
files as input data. The short reads were preprocessed by Seqman NGen to trim adaptors
and filter low-quality reads. Automatic Mer size was chosen and a minimum match
percentage of 98% was selected. 38.2 million short reads were assembled into nineteen
contigs that were ordered within SeqMan Pro (Version 12, DNASTAR, Inc. Madison, WI
U.S.) using mate pair data. The first round assembling was then used as a template for a
complete reassembly. Independently de novo assembled sequence data from other
libraries were incorporated to proof read the first assembly and to maximize coverage and
quality. Adjacent contigs, if possible, were merged. The alignment resulted a three-contig
scaffold spanning the whole genome. Gaps were filled and three contig were bridged and
circled by PCR and Sanger sequencing. No contigs remained un-assembled which might
5

corresponds to plasmids. The annotated MS14 genome, which has three chromosomes, is
available from NCBI under the accession numbers: CP009743, CP009744 and CP009745.
Other Burkholderia strains used for genome comparison
Seventeen previously sequenced Burkholderia strains were selected for
comparative genome analysis based upon their characteristics and distinctive biological
properties (Table 1.1). The selected species include MS14 and three PGPB B. lata 383, B.
ambifaria AMMD and B. phytofirmans PsJN [39-41], seven CF opportunistic pathogens
and mammalian pathogens B. thailandensis E264, B. mallei ATCC 23344, B.
cenocepacia J2315, B. multivorans ATCC 17616, B. pseudomallei 1026b, B.
pseudomallei K96243 and B. oklahomensis EO147 [42-46]. Plant pathogenic strains B.
gladioli BSR3, which infects onions, rice and iris [47], and B. glumae BGR1, which
causes bacterial panicle blight on rice [48] were selected for comparison. Another five
previously sequenced soil isolates including nitrogen-fixing nodulator that were acquired
from different habitats: B. cepacia GG4, B. phenoliruptrix BR3459a, B. phymatum
STM815, B. xenovorans LB400 and B. vietnamiensis G4 [49-52].
Comparative analyses of Burkholderia genomes
Identification of putative protein-encoding genes and annotation of B.
contaminans MS14 whole genomes were performed by NCBI Prokaryotic Genome
Automatic Annotation Pipeline (PGAAP) [53], which was designed to annotate bacterial
and archaeal genomes. Gene ontology (GO) analysis was performed by searching against
protein database using BLAST2GO [54], COG (http://www.ncbi.nlm.nih.gov/COG/) [55]
and KEGG (Kyoto encyclopedia of genes and genomes; http://www.genome.jp/kegg/)
6

[56]. Progressive Mauve [57] was used to perform the multiple genome alignments.
IslandViewer [58] was used to predict and identify genomic islands (GIs) within the
bacterial genomes with two different GIs prediction methods: SIGI-HMM [59], which
uses a hidden Markov model (HMM) [60] measuring codon usage for GIs prediction, and
IslandPath-DIMOB [61], which predicts GI based on identifying conserved regions
across all genomes and unique regions to the query genome. Secondary metabolites and
antibiotics related genes were identified using antiSMASH [62]. The average nucleotide
identity (ANI) [63] was calculated by a script developed by Kostas’s lab (http://enveomics.gatech.edu/), only the chromosome sequence of the Burkholderia strains were
taken into account. Protein coding regions were visually compared using Easyfig [64]
and genes were searched against the non-redundant database by BLASTx search. Protein
sequence identity of 40% was used as the cutoff to distinguish between peptide of similar
and non-similar structure [65]. BLASTn comparison of genomes was visualized by BRIG
[66] and Circos [67].
Identification and comparison of genetic loci associated with siderophores and
antimicrobial production, virulence factors and antibiotic resistance
The gene cluster required for production of siderophores and antimicrobial
secondary metabolites were analyzed among the selected Burkholderia genomes. The
gene clusters responsible for antimicrobial product biosynthesis were analyzed including
occidiofungin, pyrrolnitrin, pyoluteorin and lipopeptide AFC-BC11 as mentioned
previously. Burkholderia rhizoxinica produced anti-tumor product rhizoxin [68] and
Burkholderia spp. produced spliceostatin [69] were also included. The compared
siderophores include pyochelin and ornibactin.
7

Pathogenesis-related factors of Burkholderia species to both plants and mammals
were compared. Plant-toxic exopolysaccharide cepacian and toxins toxoflavin [70],
hydrogen cyanide (HCN) [71] and 2-heptyl-3-hydroxy-4(1H)-quinolone [72] were
compared within the studied genomes as plant-pathogenic agents. CF related O-antigen
of lipopolysaccharides pathogenic to mammals [73] was also compared as it is associated
with transmissible infections in CF patients.
The genes responsible for antibiotic resistance were analyzed within the
researched genomes. First, four efflux pumps are compared: BpeAB-OprB multidrug
efflux pump that is responsible for the efflux of aminoglycosides gentamicin,
streptomycin and erythromycin [74], AmrAB–OprA efflux pump that is responsible for
the extrude of aminoglycoside, macrolide, fluoroquinolones and tetracyclines [75],
BpeEF–OprC efflux pump that contributes to the resistance to chloramphenicol,
fluoroquinolones, tetracyclines and trimethoprim in clinical and environmental
Burkholderia pseudomallei isolates [76] and a salicylate-induced efflux pump that is
associated with the resistance of chloramphenicol, trimethoprim and ciprofloxacin [77].
Biofilm formation and non-replicating state alternation related genes were also compared:
first, Cep Quorum-sensing system related genes were selected for this system controls
biofilm formation that could significantly reduce antimicrobial susceptibility [78].
Second, arginine and pyruvate fermentation mechanism were analyzed for this
mechanism are among those most highly induced in response to hypoxia under anaerobic
conditions [30, 79], it is very likely that pathogenic Burkholderia bacteria utilize the
same pathway for energy generation during respiratory stress in CF patients [30].
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Moreover, beta-lactamase induced enzymatic inactivation related genes were also
analyzed due to its effects on ceftazidime and beta-lactam drug clavulanic acid [31].
Virulent features associated genes that contributes to mammalian pathogenesis
and opportunistic infections in CF were compared: Cable pili and the 22-kilodalton
adhesin biosnthesis genes that are required for Burkholderia cenocepacia binding and
transmission, the SodC gene that encodes for a Cu2+ and Zn2+ containing periplasmic
SOD that contributes to intracellular survival in CF patients, a zinc metalloprotease that
may be involved in overall virulence of several Bcc strains[80], the 31.7 kb Burkholderia
cepacia virulence genomic island that harbors multiple virulence and metabolismassociated genes, a melanin pigment that could aid the colonization and transmission of
certain B. cepacia strains in CF patients [81], in addition, the VgrG-5 protein that is
required for type VI secretion system 5 to multinucleate giant cell formation [35].
Results
Genomic features of MS14
The complete genome of B. contaminans MS14 consists of three circular
chromosomes of 3,522,585, 3,358,952, and 1,627,712 bp with a GC content of 66.89%,
66.30% and 65.50% respectively. 7813 genes were identified from the genome of which
231 were pseudogenes or partial genes. The three replicons encode 3,020, 2,943, and
1,307 predicted coding DNA sequences (CDSs), 1 noncoding RNAs (ncRNAs), 5 rRNA
operons, and 65 tRNA loci. Fourty-nine genomic islands ranging from 4 kbp to 29 kbp
were also identified by Islandviewer throughout the MS14 genome of which twenty-two
genomic islands were identified from chromosome 3 (Table 1.2). A majority of the
genomic islands genes encode hypothetical proteins. A summary of B. contaminans
9

MS14 genome features are provided in Table 1.3 and the circular chromosomes are
provided in figure 1.1.
An insight of B. contaminans MS14 genome indicated multiple predicted
antibiotic and antimicrobial production related gene loci by antiSMASH (Table 1.4),
those include five terpene and two bacteriocin biosynthesis gene clusters. Two NRPS
genes, NL30_14890 and NL30_14895 on chromosome one, share 91% and 90%
nucleotide sequence similarity with orbJ and orbI NRPS genes in the ornibactin
biosynthetic gene cluster [82], respectively. On the chromosome three, the genes
NL30_32800, NL30_32795, NL30_32790 and NL30_32785 share an overall 90%
nucleotide sequence similarity to the prnABCD genes in pyrrolnitrin biosynthetic gene
cluster [83]. In addition, two PKS genes NL30_36200 and NL30_36225 share a highest
69% and 66% amino acid sequence similarity to any published data. Strain MS14 is
likely to produce a novel bioactive compound via those two PKS genes.
BLAST searches of B. contaminans MS14 genome against B. lata 383, B.
ambifaria AMMD, B. glumae BGR1, B. cenocepacia J2315 and B. mallei ATCC 23344
genome revealed multiple unique gene regions which were only found in the MS14
genome (Figure 1.1). The BLASTn atlas showed that the MS14 chromosome is highly
similar to the PGPB B. lata 383, which is not surprising considering they belonged to
taxon K of the Bcc prior to their reassignment as two different species. However, 5% of
coding genes present in MS14 chromosome did not share significant homology with any
other species used in comparison. The BLASTn atlas also indicated MS14 chromosome 3
is more diverse than the MS14 chromosomes 1 and 2, harboring more unique gene
regions that do not share significant similarity with those in other genomes being
10

compared. Moreover, MS14 chromosome 3 harbors majority of genomic islands
identified within its genome.
GO annotations were added to MS14 genes to conduct gene analysis in population
according to analyzed transcripts [84]. GO term distribution describing molecular
function and biological process is shown in figure 1.2. MS14 genome is rich in GO terms
connected to heterocyclic compound binding and organic cyclic compound binding, that
can selectively and non-covalently interact with heterocyclic compound and organic
cyclic compound, of which many bioactive secondary metabolic are derived from. In
addition, GO terms associated with ion binding, hydrolase activity, oxidoreductase and
transferase activity are also represented in large percentage in MS14 genome.
Additionally, more than a quarter of the biological process GO terms are connected to the
metabolic process. Those data indicate that, like some Burkholderia strains [85], strain
MS14 is very versatile from the metabolic standpoint.
Phylogenetic relationships of sequenced Burkholderia species
Phylogenetic relationships of sequenced Burkholderia species were analyzed.
Strains with ANI values greater than 96%, which equate to a DNA–DNA hybridization
value of 70%, are considered to be the same species [63]. Strains with ANI value greater
than 90% are considered to have high genome relatedness. Strains with ANI value lower
than 90% are considered to have divergent genomes [86]. As shown in Table 1.5, strain
MS14 has the greatest nucleotide identity similarity to B. lata 383, which is also a novel
species within Burkholderia taxon K [40]. Soil isolate B. cepacia GG4 is most closely
related to the PGPB strains B. ambifaria AMMD. The pathogenic B. cenocepacia J2315
is also closely related to PGPB strain MS14, 383, AMMD, soil isolates GG4 and G4 than
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to other pathogenic species. Soil isolates GG4 and G4 have high genome relatedness to
pathogenic B. multivorans ATCC 17616. Plant pathogenic B. gladioli BSR3 and B.
glumae BGR1 only showed limited gene relatedness between them due to the 2 Mb
genome size difference, even though they share a similar host range. These ANI data
suggest genome sequences of the PGPB isolates are different from some virulent strains
such as B. pseudomallei 1026b, B. pseudomallei K96243 and B. mallei ATCC 23344,
which have very close phylogenetic relationship between them (ANI > 99%).
Production of siderophores and antimicrobial compounds
The genetics comparison of antibiotics production related gene among the
Burkholderia species are shown in Table 1.6. Only the core biosynthesis genes are being
compared, as indicated in the table. Intact occidiofungin biosynthesis gene is only present
in the AMMD and MS14. Several Burkholderia cepacia species were reported to produce
pyrrolnitrin. As expected, the PGPB MS14, 383, AMMD and B. oklahomensis EO147 all
harbor the intact biosynthesis gene prnABCD as a gene cluster (Figure 1.3). However,
the pyrrolnitrin biosynthesis locus was not found in B.phytofirmans PsJN. Rhizoxin’s
biosynthesis gene RhiABCDE and spliceostatin biosynthesis gene clusters were not found
in the Burkholderia genomes. Antifungal compound pyoluteorin biosynthesis genes pltB
and pltC were not found in the analyzed genomes. Intact siderophore pyochelin
biosynthesis pch gene cluster and ornibactin biosynthesis orb gene orbI and orbJ are
widely possessed among the studied genomes compared to the lipopeptide AFC-BC11,
whose biosynthesis genes afcBACD are only harbored by MS14, 383, AMMD and
pathogenic B. cenocepacia J2315. None of the antimicrobial biosynthesis genes being
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studied were identified from soil isolate B. phenoliruptrix BR3459a and plant-pathogen
bacteria B. gladioli BSR3 and B. glumae BGR1.
Virulent secondary metabolites production
Plant-virulent secondary metabolites related loci are compared and shown in Table
1.7. The cepacian biosynthesis genes are possessed among all Burkholderia genomes.
Only the two plant-pathogen BSR3 and BGR1 harbors toxoflavin biosynthesis gene toxR
and toxA-toxE homologs. Conversely, HCN and 2-heptyl-3-hydroxy-4(1H)-quinolone
biosynthesis gene pqsA-pqsE homologs are more commonly possessed by the studied
genomes. AMMD has hydrogen cyanide gene cluster identified which is not present in
the PGPB strains MS14 and 383. The overall data show MS14, 383, AMMD and other
environmental isolates have very few toxin biosynthesis genes in their genome compared
to those of the genomes of the plant pathogenic species.
Human pathogenic CF related O-antigen biosynthesis gene cluster of selected
Burkholderia species were compared, the O-antigen biosynthesis locus genetics are
shown in Figure 1.4. The 29 kb gene region of B. cenocepacia J2315 containing 24 genes
responsible for O-antigen biosynthesis and lipid A-core component was compared to the
other seventeen Burkholderia species. The homologs of first 13 genes, from waaA to
wbiF that are required for the biosynthesis of lipid A-core component, assembly initiation
of the O antigen subunits and translocation of O-antigen subunit across membrane, were
identified from the genomes of all the Bcc species analyzed in this study. The homologs
of the wbxCDEF genes that are also required for O-antigen biosynthesis were identified
from K96243, 1026b, AMMD, 17616, GG4 and EO147 genome (not shown in the
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BLAST region) but not identified from strains E264 and 23344. Possessing large amount
of genes within O-antigen cluster indicates a highly possibility of a strain’s virulence [73].
Virulence features
Pathogenic Burkholderia species including CF opportunistic isolates have more
key virulent genes identified than non-pathogenic species (Table 1.7). For example, strain
J2315 harbors intact cable pili and the 22-kilodalton adhesin biosynthesis gene. Intact
adhesin biosynthesis gene cluster was also identified from strain 17616 genome.
According to our analysis, lack of cable pili biosynthesis genes in other Burkholderia
species indicates their inability to attach to the host cell to initiate infection. The
periplasmic superoxide dismutase SodC gene [33] is commonly present among Bcc
species indicating their self-protection ability. Zinc metalloprotease biosynthesis gene
were found in the PGPB genomes; however there is no evidence showing a direct
relationship between the production of zinc metalloprotease and virulence. The 31.7 kb
Burkholderia cepacia virulence genomic island is only harbored by strain J2315. The
lack of this genomic island indicates a significant decrease in the pathogenicity potential
in other Burkholderia species. The biosynthesis gene of melanin had been identified from
all analyzed Burkholderia genomes. VgrG-5 protein biosynthesis gene is present in the
pathogenic strains E264, 23344, 1026b, K96243, EO147.
Antibiotic resistance
Antibiotic resistance is a common feature among studied Burkholderia (Table
1.7). First, our results show that the four well studied efflux pumps (AmrAB–OprA efflux
pump, BpeAB-OprB multidrug efflux pump, BpeEF–OprC efflux pump and salicylate14

induced efflux pump) are commonly present among the sequenced genomes, however the
AmrAB–OprA efflux pump was not identified from genome of strains psJN and
BR3459a. Cep quorum-sensing system is also commonly identified in the sequenced
genomes. This data indicated that the majority of the sequenced Burkholderia species
being analyzed have biofilm formation potential. However, the exceptions were psJN and
the soil isolates BR3459a, STM815 and LB400. Arginine and pyruvate fermentation
related genes were identified from PGPB strain psJN, soil isolates STM815, LB400 and
pathogenic strains E264, 23344, 1026b, K96243 and EO147. The biosynthesis of betalactamase gene was not identified from psJN, BR3459a and GG4. Taking all into account,
the results provide genetic evidence to understand Burkholderia species possess multiple
antibiotic resistance mechanism to adapt and to survival different the environment.
Overall, pathogenic Burkholderia species possess a majority of both antibiotic resistant
genes and virulence related genes. The PGPB strains, on the other hand, have the
majority of the antibiotic resistant-related genes, but lack the key virulence-related genes
like the biosynthesis genes for cable pili, adhesin and the VgrG-5 protein.
Discussion
B. contaminans MS14 is a versatile environmental isolate that shows significant
antifungal and antibacterial activity. By investigating MS14’s genome we found loci
contributing to biosynthesis several antimicrobial agents, which may partially explain its
plant growth-promoting activity. There are multiple gene regions related to antimicrobial
production or antagonistic activity. The wide spectrum of antibiotic biosynthesis genes
possessed by MS14 may contribute to its survivability when competing other soil born
microorganisms.
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Genome comparative analysis shows significant horizontal gene transfers occurred
during the evolution of MS14. The MS14 genome contains 49 genomic islands that are
absent in other studied B. contaminans genomes. One genomic island on chromosome 3
encodes a major exported protein that has a 58% amino acid identify to the type VI
secretion protein Rhs of Ralstonia sp. GA3-3 (NCBI Reference Sequence:
WP_037024668.1) [87]. This protein is predicted to facilitate the exclusion of molecules
from the cell wall and is possibly involved in the antibiotic resistance features [88]. The
acquisition and exchange of mobile genetic elements in addition to GIs has contributed to
the overall genome plasticity as well as MS41 antagonistic activities. Presumably, the
integration of new biosynthetic pathways has made the bacterial strain more adapted to
various ecological niches. The contribution of the other GIs to survival of MS14 remains
unknown, since many of the coding genes in the GIs code for hypothetical proteins.
The average nucleotide identity is one of the most robust measurements of
genomic relatedness between strains [89]. The ANI data show that the non-pathogenic
and pathogenic isolates are clustered together respectively. These results confirm that
distinct lineages exist among Burkholderia species [90]. The ANI values between B.
pseudomallei 1026b, B. pseudomallei K96243 and B. mallei ATCC 23344 were
previously shown to be all above 99%. Therefore, these three isolates can be considered
the same species according to Konstantinidis et al. [86]. However, progressive Mauve
results on chromosome 1 indicate significant gene shuffling and rearrangement between
these three species, suggesting a limited gene synteny between the isolates that have very
high ANI values (Figure 1.5). What is learned from this observations is that considerable
gene rearrangement can occur between two species that have more than 99% ANI.
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Interestingly, even pathogenic B. cenocepacia J2315 has a high genome relatedness to
PGPB (Strain MS14, 383 and AMMD), gene assessment results showed J2315 harbors
almost all key virulent related genes which are not present in the PGPB species.
Burkholderia species can have very high flexibility and mosaicism among their genomes.
These results support the notion that conventional classification of Burkholderia species
is not able to distinguish between pathogenic and nonpathogenic species and that a whole
genome comparison as was conducted with MS14 is needed to make this distinction.
MS14, as well as PGPB 383 and AMMD, has a wide range of common
antimicrobial biosynthesis gene clusters within their genomes, supporting the possible
production of multiple antimicrobial agents that contribute to their plant growthpromoting activity by inhibiting soil-borne plant pathogens, including pathogenic fungi
and bacteria. Those antimicrobial agents includes bactericidal agents like pyrrolnitrin and
bacteriostatic siderophores. Occidiofungin is highly effective in killing pathogenic fungi
by lysing cell wall or by inducing apoptosis [21, 22], however, its biosynthesis gene
cluster was not found in the closely related 383. Alternatively, other pyochelin
biosynthesis genes were found in 383 and are not present in MS14 genome. These results
show that the PGPB strains have multiple mechanisms for inhibiting competing
microorganism that increase their survivability.
Euan L.S. Thomson and Jonathan J. Dennis reported that B. vietnamiensis DBO1
harbors an occidiofungin gene cluster homolog that is related to hemolytic activity and
virulence [91]. However, two key polyketide biosynthesis genes 6477 and 6478 presented
in DBO1 that are required for full virulence were not found in the MS14 genome.
According to the author, human erythrocyte lysis activity was lost in DBO1 mutants with
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disrupted either of those two polyketide synthase genes. Conversely, hemolytic activity
can be utilized in beneficial way. For example, hemolytic bacterium Pseudomonas
entomophila had been utilized as entomopathogenic bacterium in killing insects to protect
plants [92]. Moreover, hemolytic activity has not been reported to increase a strain’s
chance of being an opportunistic microorganism. According to the same research data,
only one out of thirty CF Burkholderia isolates have detectable hemolytic activity yet
regular soil/water Burkholderia isolates shown moderate to high hemolytic activity. This
result indicates that although an occidiofungin cluster homolog was reported to be related
to B. vietnamiensis DBO1 hemolytic and virulence, the production of occidiofungin in
MS14 is not necessarily either contributing to its hemolytic activity, or increasing the
possibility of MS14’s chance of being a CF opportunistic bacterium.
Toxin biosynthesis clusters were mainly identified from pathogenic Burkholderia
species, as expected. For example, toxoflavin biosynthesis gene cluster was identified
from the plant pathogen species BSR3 and BGR1, this result further conformed their
pathogenicity in inducing bacterial blight in many field crops [47, 48] . The HCN is
extremely toxic to both plants and human beings [93, 94]. The biosynthesis genes for
HCN production is present in all pathogenic species. Additionally, all pathogenic species
in this study have the O-antigen biosynthesis related genes associated with CF patient
infection. It is not surprising that pathogenic isolates have more toxin producing genes.
However PGPB AMMD strain also has the CF related O-antigen biosynthesis genes and
hydrogen cyanide biosynthesis genes. This observation shows that the Bcc strain AMMD,
which is effective at controlling plant pathogenic fungi, may contribute to CF infections.
Given the presence of such virulence factors should raise concern for its use as a PGPB in
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agriculture. Whereas, MS14 and 383 only have the cepacian bce-I gene cluster. Since
capacian is not required for the initiation of biofilm formation and only facilitates
bacterial persistence [20, 95], the production of capacian is not a major virulence
determinant.
Antibiotic resistance is a very common feature among Burkholderia species.
Possessing multiple efflux pumps facilitates viability of bacterial cells in different
ecological niches. MS14 and 383 do not have arginine and pyruvate fermentation
mechanism related genes that are crucial in cell energy generation under low oxygen
conditions. The species that possess arginine and pyruvate fermentation are more capable
of surviving in low oxygen environments, such as the environment found in mucus of CF
patients’ respiratory system. The cells remaining latent in low oxygen environments
making them more difficult to be killed by antibiotics [30]. Lack of arginine and pyruvate
fermentation related genes in MS14 and 383 genomes indicates that both of these species
are not likely chronic opportunistic microorganisms.
PGPB and environmental isolates lack the key pathogenic feature cable pili
formation and adhesin secretion that are necessary for CF opportunistic in infection
initiation and transmission. Type VI secretion systems that have been reported to be
related to animal’s melioidosis [96] have been identified from all researched
Burkholderia genomes. However, the VgrG-5 protein, which is required for type VI
secretion system 5 to induce multinucleate giant cell formation and full virulence, has its
biosynthesis genes only identified from several pathogenic species. The melanin aids in
environmental survival, however the relationship between the production of melanin and
the increase in virulence is unknown [97]. The virulent feature comparison shows that
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PGPB and environmental isolates have less virulence related genes in their genomes,
which indicates that PGPB characterized in this study pose less risk of causing an
infection when compared to the pathogenic and CF opportunistic species.
The studied Burkholderia species can be separated into a virulent groups and a
less-virulent group based on the data summarized above. The first group includes
opportunistic pathogens, mammalian pathogens and plant pathogens. This group is highly
problematic in causing human or plant disease due to multiple virulence related genes
identified from their genomes. The less-virulent group includes plant growth-promoting
species, nitrogen-fixing nodulators and other environmental isolates that were used in the
genomic analysis. The analysis of virulence traits in the genomes of the PGPB further
conformed that the plant-associated symbiotic Burkholderia species lack hallmark
strategies required in mammalian pathogenesis as described by Angus et al. [90]. Those
studied Burkholderia species are highly unlikely to be pathogenic to either plants or
mammals based on the functional gene analysis. Whole genomic analysis approach as
described in our study, should be prompted to identify the virulence level of a
Burkholderia isolate.
Conclusion
B. contaminans MS14 has three chromosomes with a genome size of 8.5 Mb.
Multiple antibiotic and bacteriocin biosynthesis genes contribute to its overall
antimicrobial activity. BLASTn result of MS14 against other Burkholderia genomes
reveals 362 unique coding gene that are not present in other researched genomes. Fiftyone percent of the unique genes encode protein products with unknown function,
eighteen percent of the unique genes encode for metabolic and secretion system related
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proteins. ANI data indicates MS14 is closely related to B. lata 383 with a 95.28% ANI
score, and the ANI data also demonstrates the diversity of Burkholderia species genomes.
However, significant syntenic gene rearrangement can occur between two very closely
related genomes, for example, between B. pseudomallei K96243 and B. pseudomallei
1026b, which have a more than 99% ANI score. The secondary metabolites biosynthesis
genes and virulence-associated loci were compared among Burkholderia species. These
comparisons provide an insight of distinguishing between pathogenic and non-pathogenic
Burkholderia species.
MS14 has biosynthesis gene cluster identified for antibiotic occidiofungin,
pyrrolnitrin, ornibactin and AFC-BC11. Other strains, such as PGPB 383 and AMMD
also have similar antibiotic biosynthesis gene clusters identified from their genomes.
Conversely, MS14 does not have gene homologs for the production of virulent secondary
metabolite toxoflavin, hydrogen cyanide or 2-heptyl-3-hydroxy-4(1H)-quinolone, which
are commonly produced by plant pathogenic Burkholderia species. Besides, MS14 does
not harbor gene loci that are related to key virulence features possessed by human
pathogenic Bcc species. For example, MS14 does not have biosynthesis gene homologs
for cable pili, 22-Kilodalton adhesion, virulent protein VgrG-5, or the intact Burkholderia
cepacia virulence genomic island that harbors BCESM. These results indicate that MS14
has a low virulent potential and could be used to separate MS14 from the pathogenic
Burkholderia species. Consequently, soil isolates could also be distinguished from
pathogenic strains by the analysis of established virulent factors and feature genes.
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Table 1.1

List of bacteria strains used in comparative analysis.
Number
of
chromoso
mes

Size
(Mb)

GC
%

B. contaminans
MS14

3

8.509

B. lata 383

3

B. ambifaria
AMMD

Strain

Gene

CDS

66.37

7,582

7,270

Cotton field, MS, USA

8.676

66.26

7,823

7,716

Forest soil, Trinidad and
Tobago

3

7.529

66.79

6,717

6,610

Rhizosphere of healthy
pea, Wisconsin, USA

B. cenocepacia
J2315

3

8.056

66.92

7,365

7,116

CF patients, UK

B. multivorans
ATCC 17616

3

7.009

66.69

6,372

6,258

B. gladioli BSR3

2

9.052

67.41

7,757

7,411

B. glumae BGR1

2

7.285

67.93

6,302

5,773

2

5.836

68.52

5,506

5,022

2

7.314

66.94

6,357

6,264

B. phenoliruptrix
BR3459a

2

7.651

63.12

6,605

6,496

B. phymatum
STM815

2

8.677

62.28

7,899

7,496

B. phytofirmans
PsJN

2

8.215

62.32

7,484

7,241

2

7.231

68.16

6,262

6,070

2

7.248

68.05

5,935

5,727

2

6.724

67.65

5,712

5,632

Rice field. Thailand.

B. vietnamiensis
G4

3

8.391

65.73

7,861

7,617

Soil, California, USA

B. xenovorans
LB400

3

9.731

62.63

9,043

8,702

Contaminated soil, New
York, USA

B. cepacia GG4

2

6.467

66.71

5,903

5,825

Ginger rhizosphere,
Malaysia

B. mallei ATCC
23344
B. oklahomensis
EO147

B. pseudomallei
1026b
B. pseudomallei
K96243
B. thailandensis
E264
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Source

Soil enriched with
anthranilate, Berkeley,
CA, USA
Diseased rice sheath,
South Korea.
Diseased Rice Grain,
South Korea.
Glanders patient,
Myanmar
Wound infection, Georgia,
USA
Root nodule of Mimosa
flocculosa, South
America.
Root nodule of
Machaerium lunatum,
French Guiana.
Glomus vesiculiferuminfected onion roots,
plant-beneficial bacterium
Septicemic melioidosis
patient, Thailand
Septicemic melioidosis
patient, Thailand

Accession
number
CP009743,
CP009744,
CP009745
NC_007510.1,
NC_007511.1,
NC_007509.1
NC_008390.1,
NC_008391.1,
NC_008392.1
NC_011000.1,
NC_011001.1,
NC_011002.1
NC_010804.1,
NC_010805.1,
NC_010801.1
NC_015381.1,
NC_015376.1
NC_012724.2,
NC_012721.2
NC_006348.1,
NC_006349.2
CP008726.1,
CP008727.1
NC_018695.1,
NC_018672.1
NC_010622.1,
NC_010623.1
NC_010681.1,
NC_010676.1
NC_017831.1,
NC_017832.1
NC_006350.1,
NC_006351.1
NC_007651.1,
NC_007650.1
NC_009256.1,
NC_009255.1,
NC_009254.1
NC_007951.1,
NC_007952.1,
NC_007953.1
NC_018513.1,
NC_018514.1

Chromosome 2

Chromosome 1

Genomic islands of Burkholderia contaminans MS14

Chromosome 3

Table 1.2

Start (bp)
1,901,874
2,091,575
2,448,109
2,454,931
2,585,967
2,678,230
2,868,720
2,976,432
3,064,366
3,432,906
3,434,508
3,446,070
45,853
328,932
330,055
619,335
1,397,877
1,589,491
1,762,837
1,769,896
1,777,590
1,966,943
2,111,739
2,966,250
2,993,306
3,183,581
3,191,886
122,317
229,650
375,976
516,919
866,117
900,733
1,031,178
1,039,681
1,141,808
1,195,257
1,249,881
1,301,120
1,336,666
1,346,474
1,380,270
1,395,664
1,406,231
1,410,123
1,414,374
1,435,554
1,484,260
1,610,814

End (bp)
1,911,806
2,104,192
2,472,973
2,467,588
2,590,542
2,687,979
2,879,187
2,986,943
3,071,669
3,461,804
3,444,193
3,459,731
53,600
342,001
336,094
625,258
1,406,627
1,598,229
1,789,899
1,774,439
1,782,855
1,979,883
2,132,117
2,975,226
2,997,669
3,208,750
3,198,166
126,399
236,433
380,290
522,413
882,546
906,564
1,036,272
1,045,537
1,147,600
1,208,241
1,255,495
1,312,049
1,341,780
1,363,681
1,385,275
1,399,700
1,411,754
1,451,733
1,421,295
1,446,872
1,490,476
1,618,167
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Size (bp)
9,932
12,617
24,864
12,657
4,575
9,749
10,467
10,511
7,303
28,898
9,685
13,661
7,747
13,069
6,039
5,923
8,750
8,738
27,062
4,543
5,265
12,940
20,378
8,976
4,363
25,169
6,280
4,082
6,783
4,314
5,494
16,429
5,831
5,094
5,856
5,792
12,984
5,614
10,929
5,114
17,207
5,005
4,036
5,523
41,610
6,921
11,318
6,216
7,353

Table 1.3

Chromosome statistics of Burkholderia contaminans MS14

Feature
Size
Genes
CDS
Pseudo Genes
rRNAs
tRNAs
ncRNA
G+C content

Chr 3

Chr 2

Chr1

Table 1.4

Chromosome
1
3,522,585 bp
3,130
3,020
67
1
40
0
66.89%

Chromosome 2

Chromosome 3

Total

3,358,952 bp
3,049
2,943
73
3
23
1
66.30%

1,627,712 bp
1,403
1,307
91
1
2
0
65.50%

8,509,249 bp
7,582
7,270
231
5
65
1
66.40%

Secondary metabolites and antibiotics prediction of Burkholderia
contaminans MS14
Start (bp)
NL30_RS00500
NL30_RS01905
NL30_RS02655
NL30_RS05625
NL30_RS06275
NL30_RS13065
NL30_RS14795
NL30_RS17965

End (bp)
NL30_RS00585
NL30_RS02000
NL30_RS02765
NL30_RS05715
NL30_RS06440
NL30_RS13170
NL30_RS14965
NL30_RS18075

NL30_RS26845

NL30_RS27030

NL30_RS30930
NL30_RS32720
NL30_RS34320
NL30_RS36125
NL30_RS37685

NL30_RS31005
NL30_RS32905
NL30_RS34520
NL30_RS36355
NL30_RS37735

Comment
Terpene
Terpene
Hse-lactone
Terpene
Phosphonate
Terpene
NRPS: Ornibactin biosynthetic homologous cluster
Terpene
Polyhydroxyalkanoate biosynthetic gene
homologous cluster
Bacteriocin
Pyrrolnitrin biosynthetic homologous gene cluster
Occidiofungin biosynthetic gene cluster
PKS
Bacteriocin
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Table 1.5

Average Nucleotide Identity (ANI) pairwise comparisons among
sequenced Burkholderia strains

MS14

100

383

95.28

100

AMMD

91.1

91.35

psJN

83.34

83.38

83.5

100

GG4

91.62

91.7

93.45

83.5

100

BR3459a

83.59

83.63

83.64

86.89

83.73

100

STM815

83.83

83.89

83.83

84.29

83.82

85.25

LB400

83.38

83.41

83.59

90.33

83.65

87.09 84.27

G4

90.16

90.28

91.41

83.45

91.54

83.79 84.03 83.65

100

100

100

84.93

82.71

84.95

83.05 83.06 82.79

85.13

100

85.17

85.22

82.99

85.2

83.33 83.27 83.13

85.64

88.2

100

E264

86.33

86.22

86.5

83.4

86.48

83.85 83.86 83.45

86.7

84.97

85.45

100

23344

86.28

86.3

86.51

83.34

86.57

83.9

83.95 83.46

86.72

85.07

85.63

93.63

100

J2315

92.51

92.53

91.62

83.43

91.99

83.85 83.99 83.55

90.7

84.98

85.41

86.62

86.68

100

17616

89.61

89.77

89.91

83.48

90.14

83.83 84.02 83.58

90.08

84.86

85.4

86.88

86.84

90.12

100

1026b

86.14

86.18

86.37

83.28

86.47

83.79 83.83 83.46

86.56

84.92

85.41

93.6

99.36

86.55

86.7

100

K96243

86.21

86.24

86.42

83.31

86.44

83.87 83.78 83.41

86.58

84.88

85.5

93.58

99.38

86.56

86.73

99.47

100

EO147

86.3

86.34

86.63

83.35

86.55

83.89 85.25 83.53

86.69

84.89

85.56

91.98

91.94

86.56

86.76

91.74

91.81

100

383

AMMD

psJN

GG4

G4

BSR3

BGR1

E264

23344

J2315

17616

1026b

K96243

EO147

Plant growth promoting

LB400

84.75

85.14

STM815

84.78

BR3459a

BSR3
BGR1

MS14

100

Soil isolates

Pathogenic

Light grey (ANI > 90) indicates a high relatedness; dark grey (ANI > 98) indicates the
being compared objects could be considered same species.
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Table 1.6

Distribution of antibiotic and virulence compound symbiotic loci of
Burkholderia strains
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+

-

+

-
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+
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-
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+

-
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+
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+
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+

+

-

-

+

+

+

+

+

+

+
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+

+

+

+

+

+

+

-

+

+

+

+

+

17616
-

+

-

-

+

+

-

+

+

-

+

+

+

+

+

+

+

-

+

+

-

-
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+

+

+

+

+

+

+

1026b

Table 1.7

Antibiotic resistance

Pathogenic symbiotic
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+
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EO147

Figure 1.1

Circular representation of the B. contaminans MS14 genome in comparison
with five sequenced Burkholderia whole genome.

Rings from inside to outside: (1) GC content (black), (2) GC skew (purple and green), (3)
BLAST comparison with B. mallei ATCC 23344 (red), (4) BLAST comparison with B.
cenocepacia J2315 (aqua), (5) BLAST comparison with B. glumae BGR1 (slateblue), (6)
BLAST comparison with B. ambifaria AMMD (cyan), (7) BLAST comparison with B.
lata 383 (yellow), (8) Coding sequences of B. contaminans MS14 genome (dark blue),
(9) Gene islands (dark green), (10) rRNA (yellow), tRNA (dark purple) and ncRNA
(red). Figure generated by Circos with incorporated BLASTn result from BRIG.
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Figure 1.2

GO analyses of B. contaminans MS14 genome.

GO analysis of B. contaminans MS14 genome corresponding to 7,582 genes as for their predicted
involvement in molecular functions (A) and biological processes (B). Data are presented as level
3 GO categorization for molecular function and level 2 GO categorization for biological process.
Classified gene objects are depicted as gene numbers (in brackets).
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Figure 1.3

Pyrrolnitrin biosynthesis locus genetics.

Figure showing the Pyrrolnitrin biosynthesis locus identified in analyzed Burkholderia
genomes. The CDS marked in black are the prnABCD operon, which is highly conserved
in the four Burkholderia strains showing in the figure. Figure was generated by Easyfig.

Figure 1.4

CF related O-antigen biosynthesis locus genetics.

Figure showing a 29 kb gene region of B. cenocepacia J2315 containing 24 genes
responsible for O-antigen biosynthesis and lipid A-core component.
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Figure 1.5

Chromosome 1 synteny of B. mallei ATCC 23344, B. pseudomallei
K96243 and B. pseudomallei 1026b.

Pairwise alignments of genomes were generated by Mauve, Colored outlined blocks
surround regions of the genomic sequence that aligned to other genome. Colored
histogram inside blocks indicates the level of sequence similarity. Block lies above the
center line the aligned region is in the forward orientation relative to the first genome
sequence. Blocks below the center line indicate regions that align in the reverse
complement orientation. Regions outside blocks lack detectable homology among the
input genomes.
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GENETIC CHARACTERIZATION OF BURKHOLDERIA CONTAMINANS MS14
ANTIBACTERIAL ACTIVITIES
Introduction
The genus Burkholderia is composed of Gram-negative, rod-shaped, motile,
environmental versatile and non-spore-forming bacteria that have been identified in many
diverse ecological niches [1]. Currently, 88 species have been recognized in the genus
Burkholderia [2]. The bacterium has the ability to use a large array of carbon sources to
synthesize secondary metabolites [4, 5]. Burkholderia cepacia complex (Bcc) is a group
of Burkholderia species that include soil isolates and opportunistic bacteria which cause
lung disease in immunocompromised individuals [25]. The Bcc group composed of 9
different genomovars and at least 18 different species [26]. Conversely, some strains of
Burkholderia cepacia are related to the promotion of plant growth and are considered to
be plant growth-promoting bacteria (PGPB). For example, Burkholderia cepacia strains
could protect crops from fungal diseases, such as damping-off caused by Pythium
species and Rhizoctonia solani [4]. Interests in the use of Burkholderia species or their
secondary metabolites in agriculture has increased and some strains have been used in
bioremediation [4]. In addition, multiple antimicrobials have also been identified being
produced by Burkholderia species, for example occidiofungin [21], pyrrolnitrin [5],
pyoluteorin [12] and AFC-BC11 [13].
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Nonribosomal peptides, usually produced by bacteria and fungi, are a class of
peptide secondary metabolites. Nonribosomal peptides are synthesized by one or more
specialized nonribosomal peptide-synthetase (NRPS), which are independent of
ribosomal RNA [98]. The NRPS genes for a certain peptide are usually organized in one
operon in bacteria. Nonribosomal peptides often have a cyclic and/or branched structure
and can also contain non-proteinogenic amino acids. Nonribosomal peptides can be
modified by glycosylation, acylation, halogenations or hydroxylation to become
functional. The responsible enzymes are usually associated to the synthetase complex and
their genes are organized in near each other [99, 100]. Nonribosomal machinery for
peptide synthesis is usually composed of more than one NRPS modules, which form a
multienzyme complex as an assembly line to catalyze stepwise peptide condensation.
Many pharmaceutical antimicrobial agents such as penicillin precursor and vancomycin
are biosynthesized via NRPS systems. Sequence analyses of catalytic modules of NRPSs
are frequently used for product prediction [101]. The broad spectrum antifungal
compound occidiofungin of Burkholderia contaminans strain MS14 is also synthesized
by NRPS pathway [10, 21]. The domain organization of a typical nonribosomal peptide
synthetase module is shown in Figure 2.1.
Polyketide synthases (PKSs) are a family of multi-domain enzymes or enzyme
complexes that produce polyketide-type secondary metabolites in living. Similar to
NRPS genes, the PKS genes for a certain polyketide are usually organized in one operon
in bacteria. The PKS gene clusters encode different metabolic steps for a particular
biosynthetic pathway, there is usually a specific positive regulatory genes included in the
PKS gene cluster [102]. A typical PKS module also consists of several domains with
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defined functions, separated by short spacer regions organisms (Figure 2.1). Polyketides
biosynthesis pathway is similar to fatty acid synthesis. The polyketides are processed by
decarboxylative condensation of malonyl-CoA derived extender units. The polyketide
chains can be further derivatized and modified into bioactive pharmaceuticals [103].
Polyketides have various biological properties due to various molecular structures. There
are three polyketide classes: type I, type II and type III polyketides [104]. Type I
polyketides contain mainly natural product macrolides, which derivatized from a
macrolide ring which one or more deoxy sugars may be attached [105]. Many of the
macrolides have been used as antibiotics since they can inhibits protein synthesis [106].
Type II polyketides are essential for the biosynthesis of many important polycyclic
aromatic antibiotics including the anticancer agent doxorubicin [107], the antibacterial
tetracyclines [108], the antifungal drug pradimicin [109], and the antiparasitic substance
frenolicin [110]. Type III polyketides are often small aromatic molecules, for example, a
very common antimicrobial agent 2, 4-diacetylphloroglucinol (DAPG) produced by
Pseudomonads species [111].
Siderophores are small-molecule, ferric ion-specific chelating agents secreted by
bacteria and fungi growing under low iron stress. Siderophores scavenge iron from the
environment and make it available to the microbial cell [112]. Siderophores are
bacteriostatic agents that can inhibit pathogenic microorganism’s growth by depleting
iron in the soil [14]. Ornibactin [16] is a tetrapeptide siderophore that first reported being
produced by Pseudomonas [113] and by several B. cenocepacia strains [16, 114].
Ornibactin is effective in rhizosphere iron uptake and then transport of iron across the cell
wall via specific outer membrane receptors [115]. The ornibactin gene cluster contents
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two core NRPS genes for ornibactin biosynthesis [82], each of which is comprised of an
amino acid adenylation domain and a condensation domain. The two domains are core
components of NRPS mechanism, that is involved in bioactive product biosynthesis in
many microorganisms [116].
Burkholderia contaminans MS14 was isolated from soil in Mississippi and has a
broad range of antifungal activities to plant and human pathogens by producing the
oligopeptide occidiofungin [21]. Occidiofungin can significantly inhibits the growth of
pathogens by interfering with cell wall synthesis or triggering apoptosis. MS14 also
shows antibacterial activities against a wide range of plant pathogenic bacteria, which
include Erwinia amylovora, Xanthomonas citri pv. malvacearum, and Clavibacter
michiganensis subsp. michiganensis. Mutagenesis analysis of MS14 generated
antibacterial-defective mutants that retain antifungal activities as compared to the wild
strain, which indicates the antibacterial mechanism is independent from the occidiofungin
production.
Next generation high throughput transcriptional profiling (RNA-Seq) has been
utilized as an alternative to microarrays [117]. To understand genome-wide
transcriptional profiling changes related to the antibacterial activity, we used RNA-Seq to
identify the differentially expressed genes among the wide type strain MS14 and its
mutants. We also applied the RNA-seq data in this study to research the genes that are
related to MS14 antimicrobial activities.
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Materials and Methods
Bacterial strains, plasmids and culture medium
Bacterial strains and plasmids used in this study are listed in Table 2.1.
Escherichia coli strain TransforMaxTM EC100DTM pir+ (Epicentre Biotechnologies,
Madison, WI, USA) was used for plasmid rescue cloning and cultured in Luria-Bertani
(LB) medium at 37oC. Nutrient broth–yeast extract (NBY) agar medium [37] was used to
culture Burkholderia strains and for plate bioassays of the antimicrobial activities
evaluation. Potato dextrose agar (PDA, Difco, Detroit, MI) was used for plate bioassays
to evaluate antifungal activities. Antibiotics (Sigma Chemical Co., St. Louis, MO), if
applicable, were added to media as the following concentrations: trimethoprim
(50mg/mL), kanamycin (100mg/mL for Escherichia coli, 300mg/mL for Burkholderia
strains)
Bioassay for antimicrobial activities
B. contaminans MS14 and its mutants used in this study were evaluated for
antibacterial activities against Erwinia amylovora 2029 and other pathogenic indicators
(Table 2.2) using the NBY plate bioassays. The bioassay was similar to that described by
Scholz-Schroeder and colleagues [118]. Briefly, MS14 and mutants were grown
overnight in 5 ml of NBY liquid medium at 28oC. Then the bacterial cells were collected
by centrifugation and resuspended in sterile distilled water (SDW) to an optical density of
0.3 (approximately 2 ×108 CFU/ml). An aliquot (5-µl) of bacterial suspension was
inoculated onto the center of NBY plates. After the plates were incubated for 3 days at
28°C, the NBY plates were oversprayed with the suspension of indicator pathogenic
bacteria (OD420=0.3) and PDA plates were oversprayed with the indicator fungus
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(OD420=0.3), respectively. Inhibition zones were measured from the margins of bacterial
colonies 24 hours later and the size of the zone were compared between MS14 and
mutants. Three replicates for the plate bioassays were performed independently and
standard deviations of means were calculated.
Random mutagenesis
EZ-Tn5 <R6Kcori/KAN-2>Tnp Transposome kit was used as recommended by
manufacturer (Epicentre Biotechnologies, Madison, WI) to characterize the genes
dedicated to antibacterial activity of MS14. MS14 acquired kanamycin resistance on
NBY plates by the EZ::TN transposon insertion into the genome and mutants can be
selected on the NBY plates supplemented with 300 g ml-1 kanamycin. Competent cells
of strain MS14 were prepared for electroporation as described previously [117]. The
mutants that exhibited reduced or no antibacterial activity against Erwinia amylovora
were isolated. 16S rRNA and RecA genes were cloned and sequenced to confirm that the
resulting mutants were derivatives of strain MS14. Plasmid rescue cloning was performed
according to the transposome kit instructions. To confirm that the rescue plasmid
contained the transposon sequence, a portion of the Tn5 transposon sequence was
amplified by PCR with the primers R6kF1 and R6kR1. The positive rescue clones were
sequenced for further analysis. Sequence analysis was accomplished using the Lasergene
Cloning suite version 12 (DNASTAR, Inc., Madison, WI). Genes were searched against
the non-redundant database by BLASTx search. BLASTn comparison of genomes was
visualized by BRIG [66].
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Plasmid construction for complementation of mutated genes
Intact genes disrupted with insertion of transposon were amplified using primer
pairs (Table 2.3) which have specific enzyme digesting locations on both ends following
a routine PCR method [119]. The DNA fragments containing the intact wild type gene
were digested by designated enzyme, then cloned into the Burkholderia expression vector
pMLS7 [124]. The resultant plasmids were electroporated into competent cells of mutants
to recover the phenotype of the wild type strain. Empty vectors were used as negative
controls. Single colonies were picked from NBY plates supplemented with trimethoprim
(100 g ml-1) and kanamycin (300 g ml-1). Plasmids were extracted from the colonies
and sequencing result confirmed the existence of the resultant plasmids. Plate bioassays
were used to evaluate the antibacterial activity of the resulting cells as described
previously.
RNA isolation
To profile gene expression of the resulting mutants of strain MS14 and to define
the biosynthesis genes of the antibacterial activity, RNAs were prepared for
transcriptomic analysis. B. contaminans MS14 and the mutants were cultured in liquid
nutrient-broth yeast (NBY) extract medium [37] overnight in a shaker at 28oC.
RNAprotect Bacteria Reagent kit (Qiagen, Valencia, CA, USA) was used to stabilize
RNA and RNeasy Mini Kit (Qiagen, Valencia, CA, USA) was used for the bacterial total
RNA extraction as recommended by the manufacturer. RNA degradation and
contamination was monitored on 1% agarose gels. NanoPhotometer spectrophotometer
(IMPLEN, CA, USA) was used to test RNA purity. RNA concentration was measured by
using Qubit RNA Assay Kit in Qubit 2.0 Flurometer (Life Technologies, CA, USA).
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RNA integrity was assessed using the RNA Nano 6000 Assay Kit on the Bioanalyzer
2100 system (Agilent Technologies, CA, USA). The extracted total RNA was used for
the sequencing library construction.
Illumina sequencing
RNA samples (3 μg for each) were used for library preparations using NEBNext
Ultra Directional RNA Library Prep Kit (New England BioLabs, USA) following
manufacturer’s instructions. Index codes were added to the corresponding RNA samples.
Briefly, Ribo-Zero rRNA Removal Kit (Epicentre Biotechnolgies, USA) was used to
treat the total RNA, and fragmentation was carried out using divalent cations under
elevated temperature in NEBNext First Strand Synthesis Reaction Module buffer (New
England BioLabs, USA). First strand cDNA was synthesized using random hexamer
primer and M-MuLV Reverse Transcriptase (New England BioLabs, USA). Second
strand cDNA synthesis was subsequently performed using DNA polymerase I and RNase
H (New England BioLabs, USA). The resultant library fragments were purified with
AMPure XP system (Beckman Coulter, Beverly, USA) to select the preferred cDNA
fragment. The USER Enzyme (3 µl, New England BioLabs, USA) was used with sizeselected, adaptor-ligated cDNA at 37°C for 15 min followed by 5 min at 95°C before
PCR. PCR was performed with Phusion High-Fidelity DNA polymerase, universal PCR
primers and Index Primer. Finally, the products were purified by AMPure XP system and
library quality was assessed on Agilent Bioanalyzer 2100 system. The clustering of the
index-coded samples was performed on a cBot Cluster Generation System (Illumina,
USA) using TruSeq PE Cluster Kit v3-cBot-HS (Illumina, USA) according to the
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manufacturer’s instructions. The library preparations were sequenced on Illumina Hiseq
2500 platform (Illumina, USA) and 250 bp paired-end reads were generated.
Data processing and analysis
FastQC (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/) was used to test
the raw reads quality. Trimmomatic [120] was used to trim the adaptor sequences. B.
contaminans MS14 complete genome sequence (CP009743, CP009744 and CP009745)
was used as the reference for mapping. ArrayStar (Version 12, DNASTAR Inc., USA)
was used for conduct reference guided transcriptome assembling. The gene expression
was normalized by Reads Per Kilobase of transcript per Million mapped reads (RPKM)
method. HTSeq [121] was used for counting aligned reads per genes. Blast2GO [122]
and InterProScan 5 [123] were used for orthologous genes identification and adding
additional GO terms, local database was installed and used to reduce the running time.
GO terms were mapped to the GO-slim [124] to get a broad functional overview of the
transcriptome. Fisher’s exact test [125] method was used for gene set enrichment analysis
[126, 127]. KEGG database [56] was used for search of the protein functions in cell
metabolism pathway. Secondary metabolites and antibiotics related genes were identified
using antiSMASH [62]. NRPS/PKS substrate predictor was used for the polyketide gene
active domain analysis [128].
Mutagenesis of the PKS genes
NL30_RS36215 (PKSs) and NL30_RS36240 (PKSb) of strain MS14 were site-specifically mutated by insertion of the nptII cassette. Primer pairs PKSsF and PKSsR
PKSs, PKSbF and PKSbR for PKSb were designed in order to amplify the PKS gene
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NL30_RS36215 and NL30_RS36240 by PCR, respectively. The final concentrations of
PCR reagents in the 50-µL reaction mixture were MgCl2, 2 mM; dNTPs, 0.4 mM;
primers, 0.6 mM each; Taq DNA polymerase, and 0.75 units. The PCR cycling
conditions were 10 min at 95°C, and then 50 s at 95°C, 50 s at 65°C, and 2 min at 72°C
for 30 cycles, followed by 10 min at 72°C. The PCR amplicons containing parts of the
two PKS genes were cloned into the vector pGEM-T Easy (Promega) to generate the
plasmid pPKSs and pPKSb, respectively. Plasmid pBSL15 [129] was digested with KpnI
and the 1.3-kb KpnI fragment of the plasmid pBSL15 carrying the kanamycin cassette
(the nptII gene) was cloned into the PKSs and PKSb genes of the plasmid pPKSs and
pPKSb, respectively, using a KpnI partial digestion strategy. The resulting plasmids
pGEM-T Easy-PKSs::nptII and pGEM-T Easy-PKSb::nptII were named pPKSsk and
pPKSbk, respectively. The PKSs::nptII and PKSb::nptII DNA fragment were introduced
to the HindIII and SphI site of the suicide vector pBR325 [130] to generate plasmids
pPKSsk325 and pPKSbk325, respectively. The two plasmids were electroporated into the
competent cells of the wild-type MS14, respectively, which was prepared using the 10%
glycerol-washing protocol [131], for marker exchange mutagenesis (capacitance, 25 μF;
resistance, 200 Ω; voltage, 1.8 KV; and cuvette path length, 1 mm). NBY medium
containing kanamycin (300 μg/ml) was used for selection of the mutants. PCR
amplification and sequencing were used for confirmation of double-crossover
mutagenesis. Plate bioassays were used to evaluate the production and biological activity
of occidiofungin as described previously [132].
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Results
Antibacterial activity of MS14
Plate assays of strain MS14 demonstrated significant antibacterial activity against
a broad array of plant bacterial pathogens as shown in Figure 2.2 and Table 2.2.
Xanthomonas citri pv. malvacearum, one of a most destructive pathogen on cotton [133],
was best inhibited by strain MS14 with a radius of 39 mm clear non-growing zone
formed on the plate. Pectobacterium carotovorum, which is a pathogen of bacterial soft
rot on potato and other vegetables [134], Ralstonia solanacearum, which causes bacterial
wilt of tomato and potato [135], are also significantly inhibited by strain MS14. The fire
blight pathogen Erwinia amylovora of apple and pears [136] and bacterial panicle blight
pathogen Burkholderia glumae [17] are also highly sensitive to MS14 with a inhibition
zone radius of 23 mm and 22 mm, respectively. Plates assays revealed that strain MS14
could significantly inhibit the gram-positive bacteria Clavibacter michiganensis subsp.
michiganensis, the pathogen of a major tomato disease, tomato wilt and canker [137].
However, another Gram-positive pathogenic bacteria Bacillus megaterium, is not
sensitive to the growth of strain MS14 as compared to other pathogenic bacteria tested
(Data not shown). In addition, we didn’t recover any indicator bacteria from the clear
inhibition zone, which means MS14 antibacterial activities were bactericidal. Overall the
data indicate that the bioactive secondary motebolites of strain MS14 have possible
application as potent broad spectrum antibacterial agent against plant pathogens.
Identification of genes involved in production of the antibacterial product
Mutants of strain MS14 created by EZ-Tn5 transposon insertion were obtained
and were tested for antibacterial activity against Erwinia amylovora. Preliminary
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screening showed the antibacterial activity of strain MS14 mutants were eliminated or
significantly decreased against all Gram-negative indicator bacteria strains. The
antibacterial plate assays confirmed that mutants were defective in antibacterial activity
against the indicator bacteria E. amylovora, (Figure 2.3 A) but kept the same patterns of
antifungal activity against G. candidum (Figure 2.3 B) on PDA plates as that of the MS14
wild type (Only MT357 and MT577 were shown). The plate assays showed that the
antibacterial activity did not result from occidiofungin production.
Plasmid rescue method obtained plasmids from the genomes of the mutants
respectively. Plasmids details were shown in Table 2.1. BLAST analysis using the DNA
sequence generated from the plasmids pDP357 rescued from the mutant MS14MT357
against the MS14 genome showed that the disrupted gene NL30_RS14390 is 671 bp in
size that shares a 37% identity with the LuxR family transcriptional regulator Bphyt_4277
of Burkholderia phytofirmans PsJN (Figure 2.4). Similarly, the disrupted gene
NL30_RS14890 in mutant MS14MT577 is 9,662 bp in size, encoding a 3,219-aa peptide
and the deduced peptide shares a 95% identity with a NRPS protein Bcep18194_
RS14050 of Burkholderia sp. 383 (Figure 2.5). The disrupted gene NL30_RS14885 in
the mutant MS14MT530 and MS14MT134 is approximately 5,000 bp in size, which
shares a 95% identity to the NRPS gene Bcep18194_ RS14055 of Burkholderia sp. 383
(Figure 2.5). The disrupted gene NL30_RS27420 in the mutant MS14MT1116 is a 1,289
bp size glutamate--cysteine ligase gene (Figure 2.6). The disrupted gene NL30_RS30595
in MS14MT1622 is cytosol aminopeptidase gene and disrupted gene NL30_RS26125 in
MT1910 and is a hemolysin D gene, respectively (Figure 2.7 and Figure 2.8). As
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expected, the genes disrupted in the seven mutants are not associated with the ocf gene
cluster for occidiofungin production.
Complementation of the mutated genes
The intact LuxR family transcriptional regulator gene, glutamate-cysteine ligase
gene, cytosol aminopeptidase and hemolysin D gene were cloned into the Burkholderia
expression vector pMLS7, respectively, in which the closed genes were regulated by the
S7 ribosomal protein promoter [138]. The generated plasmids pDP357-2, pDP1116-2,
pDP1622-2 and pDP1910-2 were transformed into the mutants MS14MT357,
MS14MT1116, MS14MT1622 and MS14MT1910, respectively, to be expressed
constitutively. Plate bioassays revealed that the antibacterial activities of these mutants
against Erwinia amylovora had fully been restored to the wild-type level as compared
with the strain MS14 (Figure 2.9). The results suggest the genes targeted in the four
mutants are essential for production of the antibacterial activity in strain MS14.
RNA-Seq of MS14 and mutants
B. contaminans MS14 and four mutants had their RNAseq libraries constructed.
These five samples were then multiplexed and sequenced on Illumina HiSeq 2500
instrument. A total of 26,153,086 raw reads passed a quality filter and approximately 51%
were mapped to the B. contaminans MS14 genome (Table 2.4). The read counts were
normalized and gene expression was analyzed with a False Discovery Rate (FDR)
adjusted p-value < 0.05. By comparing the gene expression changes, very high
correlations were observed between MS14 and mutants (Figure 2.11). Because we were
interested in seeing what genes are lower-expressed that would lead to the antibacterial
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activity lost in the MS14 mutants, those differentially expressed genes that showed 2-fold
or lower changes in expression were targeted. There were 553, 412, 374 and 1,030 2-fold
or lower expressed genes in MT357, MT577, MT1622 and MT1910, respectively. 81
genes were globally lower expressed among all mutants (Figure 2.12), suggesting the
genes within this group may responsible for the antibacterial activity loss in all the tested
mutants.
The PKS gene cluster is responsible for MS14 antibacterial activity
A 36 Kbp polyketide biosynthesis gene cluster was identified by analyzing the
globally lower expressed genes (Figure 2.13 A). As many antibiotics were produced by
PKS gene pathway, the two PKS genes NL30_RS36215 and NL30_RS36240 within the
cluster, with size of 7,872 and 11,385 bp in size, were predicted to be directly related to
MS14 antibacterial activity. Blastp results indicated the amino acid sequence of
NL30_RS36200 shares a 71% identity with AMP-binding enzyme family protein
AJX26088, the amino acid sequence of NL30_RS36225 shares a 65% identity with the
thioester reductase domain protein in Burkholderia pseudomallei K96243, respectively.
The whole MS14 PKS gene cluster shares a 76% nucleotide sequence identity with a
PKS gene cluster in Burkholderia pseudomallei K96243, which is responsible for
biosynthesis of a virulence factor malleilactone [139]. Due to the fact that the predicted
MS14 PKS gene product (Figure 2.13 B) has a different backbone compared to that of
malleilactone, we hypothesize the MS14 PKS gene cluster encodes a novel compound
that contributes to the antibacterial activity.
Site-directed mutagenesis of the PKS genes lead to a complete loss of MS14
antibacterial activities. The band shifts confirmed the respective mutations of MT200 and
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MT225 (Figure 2.14 A). The mutants with nptII insertion were evaluated for antibacterial
compound production by inhibitory activities against the indicator bacterium E.
amylovora respectively (Figure 2.14 B). The results showed disruption of the PKS genes
NL30_RS36200 or NL30_RS36225, resulted undetectable production of antibacterial
activity against the tested bacteria as compared with the wild type strain MS14. As
expected, no changes antifungal activities of the mutants MT200 and MT225 against
fungal indicator Geotrichum candidum were observed (Figure 2.14 C), which indicates
the PKS product is independent from occidiofungin production.
Discussion
MS14 has a wide spectrum of antibacterial activity. We used eight different plantpathogenic bacterial indicators in the test and the results showed MS14’s antibacterial
activities were significant. The Tn5 transposon mutagenesis and complementation results
showed a luxR regulatory gene, a glutamate--cysteine ligase gene and a cytosol
aminopeptidase gene are directly related and required for MS14 antibacterial activities,
however those are not within the MS14 antibacterial compound biosynthetic gene cluster.
We firstly hypothesized the NRPS gene product was the antibiotic compound, the
literature research and the additional experiments conducted by Dr. James Smith’s group
at Texas A&M University (personal communication) both indicated it was a siderophore,
which is a bacteriostatic agent that can only inhibit the pathogen growth but not kill them
otherwise. This result was conflict with our observation that MS14 antibacterial activity
was bactericidal. We then were provoked to incorporate more bench experiment result
and transcriptome profiling data to looking for the antibiotic compound biosynthetic gene
cluster.
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Given the fact the relationship between the production of ornibactin and Bcc
virulence remains unclear [140], the ornibactin biosynthesis locus was compared within
Burkholderia species (Figure 2.9). B. cenocepacia J2315 is selected as the reference
given the ornibactin biosynthesis locus is best described in J2315 [43, 82]. Using this
reference the ornibactin loci were identified from thirteen Burkholderia species, which
includes the pathogenic B. multivorans ATCC 17616, B. mallei ATCC 23344, B.
thailandensis E264, B. oklahomensis EO147, B. pseudomallei 1026b and B. pseudomallei
K96243 [42, 44-46], the PGPB B. lata 383, B. ambifaria AMMD and B. phytofirmans
PsJN [39-41], soil isolates B. cepacia GG4, B. vietnamiensis G4, B. phymatum STM815
and B. xenovorans LB400 [49, 51, 52]. The comparison of ornibactin loci showed a high
degree of conservation of orbl, orbJ, orbE and pvdA genes, which are responsible for
ornibactin biosynthesis and ornibactin export across cytoplasmic membrane. Conversely,
the genes from orbS to orbB and from orbA to orbL, which involved in ornibactin
biosynthesis initiation, transportation and modification, show significant diversity within
the studied Burkholderia genomes. We also analyzed the plant pathogenic B. glumae
BGR1 and B. gladioli BSR3 [47, 48], however the ornibactin biosynthesis locus is not
identified from the two species.
During the RNA-Seq analysis, the RPKM method was used to normalize the
sequence data. There are multiple different RNA-Seq data normalization methods,
comparisons of those methods have been done and the conclusion was they vary in
performance and accuracy in different scenarios [141]. During the analysis of MS14 and
mutants’ RNA-Seq data, we found the RPKM normalization can be error-prone when
dealing with a gene that has a very low depth of coverage, which has only few or even
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zero reads mapped to it. Those errors were corrected by counting the total raw reads that
mapped to the genes.
The two PKS genes NL30_RS36215 and NL30_RS36240 identified from MS14
genome by transcriptome profiling may be directly related to MS14 antibacterial
compound production. RNA-Seq analysis demonstrated that the two genes were down
regulated in the all mutants defective in antibacterial activity. The site-specific
mutagenesis result indicated that by disrupting either of the PKS genes, MS14 mutants
MT200 and MT225 produced invisible antibacterial activity. On the other hand, mutants
MT200 and MT225 produced the same antifungal activity as the wild type strain MS14
indicating MS14 antibacterial activity derived from the PKS gene cluster is independent
of occidiofungin production. Database search found the two MS14 PKS genes shared a
76% nucleotide sequence identity with malleilactone biosynthetic gene cluster in
Burkholderia pseudomallei K96243 [126]. Malleilactone was considered to be a
virulence factor to animals with some antibiotic activities. It was showed that
malleilactone was effective in inhibiting Gram-positive bacteria (e.g., Staphylococcus
aureus and Bacillus subtilis) but has little effect to Gram-negative bacteria. However,
MS14 is effective in inhibiting Gram-negative bacteria but not to Gram-positive bacteria
such as Bacillus megaterium. Those results indicate the MS14 PKS gene cluster may
encode an antibacterial compound that is different from malleilactone. Product prediction
of the PKS synthetases also supported this hypothesis (Figure 2-12). Further research is
needed to investigate the MS14 PKS gene product chemical structure and the mechanism
of the antibacterial activities produced by MS14. Finally, MS14 antibacterial and
antifungal activities together contribute its overall significant antimicrobial activities,
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which indicates MS14 or its antimicrobial compounds can be used as potential biocontrol
agents for plant diseases.
Conclusion
This study demonstrated that Burkholderia contaminans MS14 has a wide
spectrum of antibacterial activity. Multiple genes are required for the antibacterial
activity. the NRPS gene cluster product ornibactin contributes MS14 overall antibacterial
activity and is possibly involved in regulating the MS14 antibacterial compound
production. We combined the mutagenesis and RNA-Seq data to identify a PKS gene
cluster, and according to the site-mutagenesis result, the PKS gene cluster may be
directly related to production of a novel antibacterial compound of strain MS14. This
discovery has provided important genetic clues for understanding MS14 overall
antimicrobial activities and the potential agricultural application of the antibacterial
compound.
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Table 2.1

Bacterial strains and plasmids

Strains or
Relevant characteristics
plasmids
Escherichia coli
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80dlacZΔM15 ΔlacX74 recA1
Ec100D endA1 araD139 Δ(ara, leu)7697 galU galK λ- rpsL (StrR) nupG
pir+(DHFR)
Burkholderia contaminans
MS14
Wild-type strain
MS14MT
NRPS gene NL30_RS14885::Tn5 derivative of MS14; Kmr
134
MS14MT
LuxR regulator gene NL30_RS14390::Tn5 derivative of MS14; Kmr
357
MS14MT
NRPS gene NL30_RS14885::Tn5 derivative of MS14; Kmr
530
MS14MT
NRPS gene NL30_RS14890::Tn5 derivative of MS14; Kmr
577
MS14MT Glutamate--cysteine ligase gene NL30_RS27420::Tn5 derivative of
1116
MS14; Kmr
MS14MT Cytosol aminopeptidase gene NL30_RS30595::Tn5 derivative of
1622
MS14; Kmr
MS14MT
Hemolysin D gene NL30_RS26125::Tn5 derivative of MS14; Kmr
1910
MS14MT
PKS gene NL30_RS36200:: nptII derivative of MS14; Kmr
200
MS14MT
PKS gene NL30_RS36225:: nptII derivative of MS14; Kmr
225
Plasmids
pDP134
EZ-Tn5 carrying 0.8-kb genomic DNA of MS14MT357; Kmr
pDP357
EZ-Tn5 carrying 1.2-kb genomic DNA of MS14MT357; Kmr
pDP530
EZ-Tn5 carrying 0.8-kb genomic DNA of MS14MT357; Kmr
pDP577
EZ-Tn5 carrying 0.9-kb genomic DNA of MS14MT577; Kmr
pDP1116 EZ-Tn5 carrying 0.7-kb genomic DNA of MS14MT357; Kmr
pDP1622 EZ-Tn5 carrying 1.5-kb genomic DNA of MS14MT357; Kmr
pDP1910 EZ-Tn5 carrying 0.9-kb genomic DNA of MS14MT357; Kmr
pMLS7
Expression vector of Burkholderia; Tpr
pMLS7 carrying 828bp BamHI and HindIII fragment containing the
pDP357-2
intact LuxR gene NL30_RS14390; Tpr
pDP1116- pMLS7 carrying 1316bp EcorR1 and HindIII fragment containing the
2
intact glutamate--cysteine ligase gene NL30_RS27420; Tpr
pDP1622- pMLS7 carrying 1536bp BamHI and HindIII fragment containing the
2
intact cytosol aminopeptidase gene NL30_RS30595; Tpr
pDP1910- pMLS7 carrying 1304bp BamHI and HindIII fragment containing the
2
intact hemolysin D gene NL30_RS26125; Tpr
pBR325
Cloning vector; Cmr Tcr Apr
pGEM-T
Cloning vector; Apr
Easy
pBSL15
Kanamycin resistance gene cassette; Kmr
pGEM-T Easy carrying 1.1 kb PCR product containing part of PKS
pPKSs
gene NL30_RS36215; Apr
pPKSb
pGEM-T Easy carrying 1.3 kb partial PKS gene NL30_RS36240; Apr
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Source or
reference
Epicentre
Corporati
on

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
[138]
This study
This study
This study
This study
[130]
Promega
[129]
This study
This study

Table 2.1 (Continued)
pPKSsk
pPKSbk
pPKSsk32
5
pPKSbk32
5

pGEM-T Easy carrying 2.4 kb partial PKS gene
NL30_RS36215::nptII; Kmr
pGEM-T Easy carrying 2.6 kb partial PKS gene
NL30_RS36215::nptII; Kmr
pBR325 carrying 2.4 kb HindIII/SphI fragment containing partial
PKS gene NL30_RS36200::nptII; Kmr Tcr Apr
pBR325 carrying 2.6 kb HindIII/SphI fragment containing partial
PKS gene NL30_RS36225::nptII; Kmr Tcr Apr

This study
This study
This study
This study

Kmr, Tpr, Tcr and Apr stands for kanamycin, trimethoprim, tetracycline and ampicillin
resistance, respectively.

Table 2.2

Antibacterial activities of Burkholderia contaminans MS14

Indicator Pathogenic Bacteria
Xanthomonas citri pv. malvacearum MSCT1
Pectobacterium carotovorum subsp. carotovoro WSCH1
Ralstonia solanacearum 102
Pseudomonas syringae B301
Erwinia amylovora 2029
Burkholderia glumae 291
Escherichia coli JM109
Clavibacter michiganensis subsp. michiganensis 1-07
Bacillus megaterium Km
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Inhibition Zone Radius
(mm)
36±1.66
33±0.86
31±0.08
29±1.00
23±0.85
22±0.08
22±0.77
17±0.07
2.5±0.04

Table 2.3

Primers used in this study

Primer
R6kF1
R6kR1
1116F
1116R
1622F
1622R
1910F:
1910R:
LuxRF
LuxRR
PKSsF
PKSsR
PKSbF
PKSbR

Table 2.4

Sequence (5’-3’)
GGGTAGCCAGCAGCATCCT
CATGATCGTGCTCCTGTCGTT
CGCGAGAATTCCATGGTTCCCCACCTCG
CGTAAAGCTTGTCCGTTACACCTGG
GACAGGATCCATGGACTTTAGCATAA
TCGTAAGCTTCGCCATCACTGGCCGGC
GAAAGGATCCCCCTGTTATTGCG
CACAGAAGCTTCTCCATGCGCGTCGAA
CTGAGGATCCATTCAAACTAAACGAACGGGG
GACGAAGCTTTGGCTCAGCGCGTTTC
CCCAAGCTTCGCGAATCTGCCGGAATACG
ACATGCATGCGCTCGCCGCCGCATCAAA
CCCAAGCTTCGCTGACCGCCCTCCATCT
ACATGCATGCTTCCATCGCCGGGTTCGTC

RNA-Seq reads and mapping statistics

Sample
B. contaminans
MS14
MT357
MT577
MT1622
MT1910

17,571,626

Total
Clean
Reads
16,908,101

Reads
Quality >Q30
(%)
88.44

14,388,794

Percent
Mapped
(%)
85.1

18,997,816
18,053,092
17,541,622
17,850,428

18,241,488
17,209,564
16,799,898
16,994,035

88.97
88.66
88.53
88.42

15,446,892
14,414,731
14,143,834
15,026,126

84.68
83.76
84.19
85.2

Total Raw
Reads
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Reads
Mapped

Figure 2.1

Domain organization of a typical polyketide synthase module and
nonribosomal peptide synthetase module.

a, A polyketide synthase module is minimally comprised of three distinct domains: a
condensation (KS, ketosynthase), an acyltransferase (AT), and an acyl carrier protein
(ACP) domain. The electrophile (shown in blue) is recognized by and attached to the KS
domain, whereas the nucleophile (shown in red) is recognized by the AT domain, which
attaches this moiety to the 'swinging arm' of the ACP domain (wavy line). The C–C bond
formed between the electrophile and the nucleophile is shown in black.
b, Likewise, a non-ribosomal peptide synthetase module is also minimally comprised of
three distinct domains: a condensation (C), an adenylation (A), and a peptidyl carrier
protein (PCP) domain. The electrophile (shown in blue) is recognized by the C domain
(although it is not believed to bind covalently to this domain, hence shown attached to the
previous domain (dashed line)), whereas the nucleophile (shown in red) is recognized by
the A domain, which attaches this moiety to the 'swinging arm' of the PCP domain (wavy
line). The amide bond formed between the electrophile and the nucleophile is shown in
black
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Figure 2.2

Antibacterial activity of Burkholderia contaminans MS14.

Indicator used were: (1) Xanthomonas citri pv. malvacearum MSCT1, (2) Pectobacterium
carotovorum WSCH1, (3) Ralstonia solanacearum MS444, (4) Pseudomonas syringae pv.
syringae B301, (5) Erwinia amylovora 2029, (6) Burkholderia glumae 291, (7)
Escherichia coli JM109, and (8) Clavibacter michiganensis subsp. michiganensis 1-07.
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Figure 2.3

Antimicrobial activity of Burkholderia contaminans strain MS14 and
mutants.

The mutants lost antibacterial activities against Erwinia amylovora (A). The mutants kept
same antifungal activity against Geotrichum candidum compared to wild type strain (B).

Figure 2.4

A 10 Kb genomic region of the Burkholderia contaminans strain MS14
with the mutation location 357.
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Figure 2.5

A 34 Kb genomic region of the Burkholderia contaminans strain MS14
with the mutation location 134, 530 and 577.

Figure 2.6

An 11 Kb genomic region of the Burkholderia contaminans strain MS14
with the mutation location 1116.

Figure 2.7

A 10 Kb genomic region of the Burkholderia contaminans strain MS14
with the mutation location 1622.
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Figure 2.8

A 14 Kb genomic region of the Burkholderia contaminans strain MS14
with the mutation location 1910.
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Figure 2.9

Constitutive expression of mutated genes restore the antibacterial activity.
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Figure 2.10

Ornibactin biosynthesis locus genetics of Burkholderia species.
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Figure 2.11

Transcriptome scatter plot MS14 and mutants.

Genes were normalized by RPKM method. Black data points indicate genes that show 2
fold or greater changes in expression with a FDR adjusted p < 0.05, R2 (Linear
Correlation) equals 0.927, 0.9529, 0.9488 and 0.8351, respectively. The gene expression
difference was represented on the axis with a log2 scale.
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Figure 2.12

Venn diagram showing the overlap of differentially expressed genes in the
MS14 mutants.

81 genes were globally differentially expressed at 2-fold or lower change in all tested
mutants.

Figure 2.13

The 36 Kbp MS14 polyketide biosynthesis gene cluster (A) and predicted
antibacterial compound (B).
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Figure 2.14

Confirmation of site-specific mutagenesis of the two PKS synthetase genes
and plate bioassays of antimicrobial activities of strain MS14 mutants.

Band shifts confirmed the inspectional mutations (A), PKS gene NL30_RS36225 was
amplified (1, 2 and 3) and PKS gene NL30_RS36200 was amplified (4, 5 and 6)
respectively. Antibacterial activity of Burkholderia contaminans strain MS14 against
Erwinia amylovora was lost in MT200 and MT225 (B). Antifungal activity of B.
contaminans strain MS14, MT200 and MT225 against Geotrichum candidum (C).
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COMPLETE GENOME OF PSEUDOMONAS CHLORORAPHIS STRAIN UFB2
Introduction
Bacterial strains of Pseudomonas chlororaphis are aerobic Gram-positive bacteria
and many of the strains possess a wide-spectrum antifungal activity against soil-borne
plant pathogens [142-146]. P. chlororaphis strains have been reported to be efficient
plant-growth-promoting bacteria, which can be used as inoculants for biofertilization,
phytostimulation and biocontrol [147]. The use of P. chlororaphis strains as biocontrol
agents is promising because they are capable of producing a variety of antimicrobial
secondary metabolites including phenazine-1-carboxamide, 2-hydroxyphenazine,
pyrrolnitrin, hydrogen cyanide, chitinases and proteases [147-149]. Moreover, P.
chlororaphis is considered to be nonpathogenic to humans, wildlife, or the environment
according to U.S. environmental protection agency (EPA) [150]. Antimicrobial activities
and low risks to animals and the environments have made the bacterium P. chlororaphis
highly potential biocontrol agents in agriculture [149, 151]. A genome-wide research and
analysis could provide useful information about the mechanisms of how P. chlororaphis
protects plants against soil-borne phytopathogens. Currently, the whole genomes of a few
P. chlororaphis strains that exhibit antifungal activity have been sequenced. These
include P. chlororaphis strain PA23 that can protect canola from stem rot disease caused
by the fungal pathogen Sclerotinia sclerotiorum [143, 152], and P. chlororaphis
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PCL1606 that was isolated from avocado rhizosphere and exhibited biocontrol activity
against soil-borne phytopathogenic fungi [142]. In addition, another functionallyuncharacterized strain, P. chlororaphis subsp. aurantiaca JD37, was recently sequenced
(NCBI reference sequence: NZ_CP009290.1). Genome sequences of P. chlororaphis
strains with significant antibacterial activity have not been reported previously.
Strain UFB2 was isolated from a soybean field soil in Mississippi. Preliminary
analysis of the 16S rRNA gene indicated that it is a member of P. chlororaphis. Plate
assays indicated P. chlororaphis strain UFB2 has a broad spectrum of antimicrobial
activities, especially against bacterial canker pathogen of tomato: Clavibacter
michiganensis [153, 154]. Greenhouse trials demonstrated both living cells and culture
extract of strain UFB2 can be used for disease management of bacterial canker of tomato.
In this study, the P. chlororaphis strain UFB2 complete genome sequence and annotation
are reported. The gene islands within strain UFB2 genome that encode various secondary
metabolites, including antimicrobial compounds, are also described. The detailed
description of the strain UFB2 genome will shed light into further studies of biocontrol
effectiveness and applications of Pseudomonas species.
Materials and Methods
Growth conditions and genomic DNA preparation
P. chlororaphis strain UFB2 was cultured in liquid NBY medium overnight at
28oC in a shaker at 220 rpm. The genomic DNA was extracted from 50 mL of the culture
using the Wizard Genomic DNA Purification Kit (Promega Corporation, Madison, WI,
USA). Totally approximately 900 µg of DNA were obtained with an OD260/280 of 1.9.

64

The DNA sample was used for library construction with Illumina Genomic DNA Sample
Preparation Kit (Illumina, CA, USA).
Bioassay for antimicrobial activities
P. chlororaphis strain UFB2 were evaluated for antibacterial activities against
Clavibacter michiganensis 1-07 using the NBY plate bioassays. The bioassay was similar
to that described by Scholz-Schroeder and colleagues [118]. Briefly, UFB2 was grown
overnight in 5 ml of NBY liquid medium at 28oC. Then the bacterial cells were collected
by centrifugation and resuspended in sterile distilled water (SDW) to an optical density of
0.3 (approximately 2 ×108 CFU/ml). 5-µl aliquots of bacterial suspension were
inoculated onto the center of NBY plates. After the plates were incubated for 3 days at
28°C, the NBY plates were oversprayed with suspension of indicator pathogenic bacteria
(OD420=0.3). Inhibition zones were measured from the margins of bacterial colonies 24
hours later.
Genome sequencing and assembly
One standard library with an average insert size of 400 bp and three mate pair
libraries with an average insert size of 2,000 bp, 5,000 bp and 8,000 bp were prepared
and sequenced on the Illumina MiSeq instrument according to the manufacturer’s
instructions. The genome was de novo assembled using a method as described by Durfee
et al [38] using DNAStar Seqman NGen (Version 12, DNASTAR, Inc. Madison, WI
U.S.). The standard library and 2,000 bp mate pair library were selected for the de novo
assembly. A total of 30 million short reads were scanned and extracted from the raw data
files as input data. The short reads were preprocessed by Seqman NGen to trim adaptors
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and filter low-quality reads. Automatic Mer size and a minimum match percentage of 98%
were selected. 29 million short reads were assembled into 29 contigs and SeqMan Pro
(Version 12, DNASTAR, Inc. Madison, WI U.S.) was used to order the contigs in one
scaffold according to the mate pair data. The first round assembled sequence was then
used as a template for a complete reassembly. The 2,000 bp and 8,000 bp mate pair data
were incorporated to proofread the first assembly and to maximize coverage and
quality. Adjacent contigs, if possible, were merged. Remaining gaps were filled by PCR
and Sanger sequencing. No contigs that might correspond to plasmids remained
unassembled. IslandViewer [155] was used to predict and identify genomic islands.
Genome annotation
Automatic annotation was performed using the NCBI Prokaryotic Genome
Annotation Pipeline [156], which combines gene calling algorithm with similarity-based
gene detection approach to predict protein-coding genes, structural RNAs (5S, 16S, 23S),
tRNAs and small non-coding RNAs. Additional gene prediction analysis and functional
annotation were performed by the Integrated Microbial Genomes (IMG) platform [157].
The genome project is deposited in the Genomes OnLine Database [158] and the NCBI
BioProject database [159]. The annotated genome is publicly available from the
Intergrated Microbial Genomes (IMG) Database [157] under the accession number
Gp0111981 and GenBank under accession number CP011020.
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Results
Classification and features
Strain UFB2 was isolated from rhizosphere soil sample collected from soybean
field near Cleveland, Mississippi, USA, where healthy soybean plants were found
growing in charcoal rot disease patch. Phylogenetic analyses based on multilocus
sequence typing [160] (gyrB, rpoB, rpoD and 16s rRNA) revealed that strain UFB2
belongs to Pseudomonas chlororaphis (Figure 3.2). Strain UFB2 is rod-shaped, motile,
non-spore-forming Gram-negative bacterium in the order Pseudomonadales of the class
Gammaproteobacteria. UFB2 cells are approximately 3.0±0.8 μm in width and 0.9±0.3
μm in length (Figure 3.1). The strain is relatively fast-growing, forming approximately 1
mm opaque yellowish colonies after overnight incubation at 28°C on nutrient-broth yeast
extract agar [37]. Strain UFB2 can also be grown on rich media such as LB [161] and
PDA, as well as M9 minimal medium [162]. Phenotypic characterization of strain UFB2
was analyzed by API 50CH systems as recommended by manufacturer. According to the
result, strain UFB2 could utilize almost all carbon sources in API 50CH tests, including
D-glucose, D-galactose, L-rhamnose, D-mannitol, D-raffinose, D-fructose, D-arabinose,
D-ribose, L-arabinose, L-xylose and D-xylose, but not potassium gluconate.
Plate bioassays demonstrated that strain UFB2 possesses significant antibacterial
activity against a broad array of plant bacterial pathogens. Other than Clavibacter
michiganensis 1-07, the tested bacteria sensitive to strain UFB2 also include Erwinia
amylovora [163, 164], Burkholderia glumae [165], Ralstonia solanacearum Rso [166,
167] and Erwinia carotovorum WSCH1 [164, 168]. Of the tested plant pathogenic
bacteria, the Gram-positive bacterium Clavibacter michiganensis 1-07, the pathogen
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causing bacterial canker of tomato [137], is most sensitive to strain UFB2 with a radius of
28±1 mm clear inhibitory zone (Figure 3.1). In addition, the growth of fungal pathogen
Geotrichum candidum Km, which causes sour rot of citrus fruits, tomatoes, carrot and
some vegetables [169], can also be inhibited by strain UFB2. To test the field biocontrol
efficacy of strain UFB2, greenhouse experiments were set up according to the method
described by Lu and Ingram [170]. Preliminary data showed the control efficacies of both
strain UFB2 culture extract and living cells on bacterial canker of tomato are equivalent
to that of streptomycin at the recommended rate for plant disease management. The
genome of strain UFB2 was sequenced with the aim to identify the genes associated with
the antimicrobial characters. The information about the genome sequence of strain UFB2
is summarized in Table 3.1, and its phylogenetic position is shown in Figure 3.2.
Fatty acid analysis was performed by gas chromatography (gas chromatograph,
model 6890 N, Agilent Technologies) and analyzed by the Microbial Identification
System (MIDI, Sherlock Version 6.1; database, TSBA40). The analysis of total cells
showed the major fatty acids are C 16:1ω7c (32%), C 16:0 (28%), C 18:1ω7c (19%). Fatty acid
3-hydroxy C 12:0 (5%), C 12:0 (4%), 2-hydroxy C 12:0 (4%) and 3-hydroxy C 10:0 (3%) were
found in minor amount.
Genome Properties
The complete genome of P. chlororaphis strain UFB2 consists of one circular
chromosome of 6,360,256 bp with a GC content of 62.03%. 5,556 genes were identified
from the genome, of which 5,473 are protein coding genes. 90 of the 5,556 genes were
predicted to be pseudogenes or partial genes. The genome encodes 1 noncoding RNA, 5
rRNA operons and 65 tRNAs. Seventy genomic islands ranging from 4 kbp to 43.5 kbp
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were also identified throughout the strain UFB2 genome, among which majority of the
islands encode hypothetical proteins. The UFB2 sequencing information summary is
provided in Table 3.2. The genome features of P. chlororaphis strain UFB2 are
summarized in Table 3.3 and the circular chromosome of strain UFB2 is shown in Figure
3.3. Number of genes associated with general COG functional categories are shown in
Table 3.4.
Discussion
Comparative genomics approaches were applied to research strain UFB2’s unique
genome regions compared to the genomes of closely related species. Blast research of P.
chlororaphis strain UFB2 genome against P. syringae pv. syringae B728a (NC_007005),
P. putida KT2440 (NC_002947), P. chlororaphis strain PA23 (NZ_CP008696), P.
aeruginosa PAO1 (NC_002516), P. fluorescens Pf0-1 (NC_007492) and P. sp. UW4
(NC_019670) genome revealed multiple unique genomic regions which were only found
in the strain UFB2 genome (Figure 3.3). The BLASTn atlas showed noticeable genome
diversity of strain UFB2 when compared to other Pseudomonas species. Seventy
genomic islands ranging from 4 kbp to 30 kbp were also identified throughout the strain
UFB2 genome, indicating a significant horizontal gene transfers occurred during the
evolution of strain UFB2 to better adapt the environment it habituated.
We also studies the secondary metabolites biosynthetic gene clusters in P.
chlororaphis strain UFB2 genome. The strain UFB2 genome harbors an intact phl gene
cluster (VM99_23970-23995), which is responsible for biosynthesis of the antimicrobial
compound 2,4-diacetylphloroglucinol [111, 171]. 2,4-diacetylphloroglucinol is an
especially efficient agent against soil borne fungal plant pathogens [172]. The phl gene
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cluster is involved in the Pseudomonas antifungal activity against Clavibacter
michiganensis 1-07 [173]. Hydrogen cyanide [174, 175] biosynthesis gene homologs
were also identified in strain UFB2 genome. The production of hydrogen cyanide by
Pseudomonas species helps protect plants from soil borne fungal pathogens [176, 177].
Biosynthetic gene clusters of common Pseudomonas species-produced antibiotics such as
phenazine [178], pyrrolnitrin [83] and pyoluteorin [179] were not identified in strain
UFB2 genome. Biosynthetic gene clusters of common toxins that contribute to plant and
animal pathogenicity and/or virulence of Pseudomonas species were also searched for
within strain UFB2 genome. The toxin biosynthetic gene clusters that were not identified
in strain UFB2 genome include the phytotoxin lipopeptide syringomycin [118], tobacco
wildfire spotting causal agent tabtoxin [180], bacterial canker of kiwifruit causal agent
phaseolotoxin [181], plant-hormone-mimic toxin coronatine [182], and cytotoxic agent
pederin [183]. Strain UFB2 genome harbors homolog genes to those in the bacterial
apical necrosis causal agent mangotoxin [184] biosynthesis gene cluster. However, mboC
gene homolog that is required for mangotoxin production [185] was not identified in
strain UFB2 genome. Overall, the lack of the key pathogenicity/virulence genes in strain
UFB2 further indicates that strain UFB2 has a great potential as a biocontrol agent.
Conclusion
The complete genome sequence of P. chlororaphis strain UFB2 is described in
this report. The strain UFB2 was originally isolated from the rhizosphere of a healthy
soybean plant growing in a group of plants exhibiting charcoal rot disease in Mississippi.
This strain possesses significant antimicrobial activities against a wide range of plant
pathogenic bacteria and fungi. It is evident that the genome of P. chlororaphis strain
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UFB2 harbors the complete gene set for production of the antimicrobial compounds 2,4DAPG and HCN, which may largely contribute to its antimicrobial activities. However,
gene homologs required for biosynthesis of all the known toxins to plants, such as
syringomycin, tabtoxin, phaseolotoxin, tolaasin, coronatine, or pederin, were absent from
the strain UFB2 genome. The genome sequence of P. chlororaphis strain UFB2 will help
in understanding genetic mechanisms of the antimicrobial activity studies that are useful
for development of biologically-based disease management in agriculture.
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Table 3.1

Classification and general features of Pseudomonas chlororaphis UFB2.

MIGS ID

Property

Term

Evidence code

Classification

Domain Bacteria

TAS [186]

Phylum Proteobacteria

TAS [187]

Class Gammaproteobacteria

TAS [188, 189]

Order Pseudomonadales

TAS [164, 190]

Family Pseudomonadaceae

TAS [164, 191]

Genus Pseudomonas

TAS [191-193]

Species Pseudomonas chlororaphis

TAS [194]

strain: UFB2

NAS

Gram stain

negative

TAS

Cell shape

Rod

TAS

Motility

Motile

TAS

Sporulation

None

NAS

Temperature range

Mesophilic

IDA

temperature

33°C

IDA

pH range; Optimum

not determined

IDA

Carbon source

D-glucose,

Optimum

D-galactose,

L-

rhamnose, D-mannitol, D-raffinose,
D-fructose, D-arabinose, D-ribose,
L-arabinose, L-xylose, D-xylose.

TAS

MIGS-6

Habitat

Soil

NAS

MIGS-6.3

Salinity

not determined

IDA

MIGS-22

Oxygen requirement

Aerobic

NAS

MIGS-15

Biotic relationship

free-living/ Rhizospheric

NAS
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Table 3.1 (Continued)
MIGS-14

Pathogenicity

non-pathogen

IDA

MIGS-4

Geographic location

Mississippi, USA

IDA

MIGS-5

Sample collection

2011

IDA

MIGS-4.1

Latitude

34.1N

IDA

MIGS-4.2

Longitude

90.6W

IDA

MIGS-4.4

Altitude

40M

IDA

Classification and general features were assigned according to MIGS recommendations
[173]. Evidence codes - IDA: Inferred from Direct Assay; TAS: Traceable Author
Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author
Statement (i.e., not directly observed for the living, isolated sample, but based on a
generally accepted property for the species, or anecdotal evidence). These evidence codes
are from the Gene Ontology project [183].
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Table 3.2
MIGS ID

UFB2 sequencing project information.
Property

Term

MIGS 31

Finishing quality

Finished

MIGS-28

Libraries used

MIGS 29

Sequencing platforms

libraries of 400 bp, mate pair library of 2,000,
5,000 and 8,000 bp
Illumina

MIGS 31.2 Fold coverage

600X

MIGS 30

Assemblers

DNAStar Seqman NGen v12

MIGS 32

Gene calling method

NCBI Prokaryotic Genome Annotation Pipeline

Locus Tag

VM99

Genbank ID

CP011020

GenBank Date of Release

Mar 31, 2016

GOLD ID

Gp0111981

BIOPROJECT

PRJNA277727

Source Material Identifier

UFB2

Project relevance

Biocontrol

MIGS13
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Table 3.3

Pseudomonas chlororaphis UFB2 Genome statistics
Attribute

Value

% of Total

Genome size (bp)

6,360,256

100.00

DNA coding (bp)

5,588,126

87.86

DNA G+C (bp)

3,945,558

62.03

DNA scaffolds

1

100.00

Total genes

5,556

100.00

Protein coding genes

5,473

98.51

RNA genes

83

1.49

Pseudo genes

90

1.62

Genes in internal clusters

5,473

98.51

Genes with function prediction

4,886

87.94

Genes assigned to COGs

4,092

73.65

Genes with Pfam domains

4,748

85.46

Genes with signal peptides

577

10.39

1,228

22.10

0

0

Genes with transmembrane helices
CRISPR repeats
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Table 3.4

Number of genes associated with general COG functional categories

Code

Value

%age

Description

J

231

4.89

Translation, ribosomal structure and biogenesis

A

1

0.02

RNA processing and modification

K

418

8.85

Transcription

L

123

2.60

Replication, recombination and repair

B

3

0.06

Chromatin structure and dynamics

D

39

0.83

Cell cycle control, Cell division, chromosome partitioning

V

101

2.14

Defense mechanisms

T

316

6.69

Signal transduction mechanisms

M

262

5.55

Cell wall/membrane biogenesis

N

166

3.52

Cell motility

W

44

0.93

Extracellular structures

U

137

2.90

Intracellular trafficking and secretion

O

166

3.52

Posttranslational modification, protein turnover, chaperones

C

304

6.44

Energy production and conversion

G

227

4.81

Carbohydrate transport and metabolism

E

483

10.23

Amino acid transport and metabolism

F

92

1.95

Nucleotide transport and metabolism

H

242

5.12

Coenzyme transport and metabolism

I

234

4.96

Lipid transport and metabolism

P

257

5.44

Inorganic ion transport and metabolism

Q

142

3.01

Secondary metabolites biosynthesis, transport and catabolism

R

430

9.11

General function prediction only

S

260

5.51

Function unknown

-

1464

26.35

Not in COGs
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Figure 3.1

Image of P. chlororaphis UFB2 cells (left) and plate assay of UFB2
antibacterial activity against Clavibacter michiganensis 1-07 (right).

The plate bioassay was conducted as described by Scholz-Schroeder and colleagues
[104].
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Figure 3.2

Circular representation of the P. chlororaphis UFB2 genome compared
with six sequenced Pseudomonas whole genomes.

Rings from inside to outside: (1) Scale, (2) GC content (navy), (3) GC skew (purple), (4)
BLAST comparison with P. syringae pv. syringae B728a (deep pink), (5) BLAST
comparison with P. putida KT2440 (pink), (6) BLAST comparison with P. chlororaphis
strain PA23 (cyan), (7) BLAST comparison with P. aeruginosa PAO1 (violet), (8)
BLAST comparison with P. fluorescens Pf0-1 (skyblue), (9) BLAST comparison with P.
sp. UW4 (yellow), (10) Coding sequences of P. chlororaphis UFB2 genome (dark cyan),
(11) Gene islands (medium purple), (12) rRNA genes (orange), tRNA genes (dark green)
and ncRNA (red). BLASTn comparison of genomes was visualized by BRIG [66] and
UFB2 genome the image was generated with Circos [67].
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GENETIC CHARACTERIZATION OF PSEUDOMONAS CHLORORAPHIS STRAIN
UFB2 ANTIMICROBIAL ACTIVITIES
Introduction
Biological control is the use of natural or modified organisms, genes, or gene
products, to reduce the effects of undesirable organisms such as plant pathogens and to
favor desirable organisms such as crops, and is an important component of integrated pest
management [195]. It may also provide effective management of plant diseases that
cannot or only partially be managed by other control strategies. Research on novel
biological control agents could facilitate in developing commercialized products.
Antagonistic microbes present in disease-suppressive soils are important
resources of genetic materials for developing transgenic crops and biological control
agents [196]. Soilborne pathogens do not become established or cause little or no damage
to the host plant in pathogen-suppressive soils [195]. Pathogen-suppressive soils have
been found in fields infected by various soilborne diseases such as those caused by
Rhizoctonia solani and Erwinia carotovora [197]. Bacterial species of the genera
Pseudomonas, Bacillus, Enterobacter and Streptomyces as well as species of the fungal
genera Trichoderma and Gliocladium are frequently identified from suppressive soils
[198, 199]. Therefore it is possible to find the mechanisms of how the pathogenic
microorganisms are inhibited in suppressive soils. Usually the pathogens are suppressed
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by more than one way. Antibiotic syntheses, competitions and hyperparasitism are
involved in those mechanisms [200-203]. For example, certain members of the genus
Pseudomonas have been applied to cereal seeds or applied directly to soils as a way of
preventing diseases. P. fluorescens might induce systemic resistance in the host plant, so
the host can better resist attack by a true pathogen [204]. P. chlororaphis, which produces
a phenazine-type antibiotic, suppresses plant disease development caused by fungal
pathogens [148]. The antagonistic compound di-2,4-diacetylfluoroglucylmethane
produced by P. aurantiaca, can also help protect plants against Gram-positive plant
pathogens [205]. More research is necessary to determine the mechanisms involved in
pathogen suppression and develop new antibiotics that can be used in biological controls.
The genus Pseudomonas contains 191 validly described species [206]. Most of
them have a widespread occurrence in water and soil. Some Pseudomonas strains can be
used as biological agents. Since the mid-1980s, some strains of the Pseudomonas group
have been used as seed inoculants on crop plants to promote growth and increase yields
result from their antagonism to potentially deleterious fungi and bacteria [207]. Inducing
host plant resistance, competitions and antibiotic productions [204] are common
mechanisms to suppress other pathogenic organisms. Siderophores could give a
competitive advantage at scavenging for iron [207] so other microorganisms which
require iron cannot not grow well. P. chlororaphis PCL1391 was reported be essential for
biocontrol of tomato foot and root rot [208]. P. putida is capable of control damping off
diseases such as Pythium [209] and Fusarium [210] and P. aurantiaca can help host plant
resist Gram-positive organisms by producing di-2,4-diacetylfluoroglucylmethane [205].
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Strain UFB2 was isolated from the rhizosphere of a healthy soybean plant
growing in a charcoal rot disease patch in Mississippi. The multilocus sequence typing
result showed strain UFB2 belongs to Pseudomonas chlororaphis. Mutagenesis revealed
that strain UFB2 produces 2,4-Diacetylphloroglucinol, which is responsible for its
antibacterial activity against Clavibacter michiganensis subsp. michiganensis, the causal
agent of the devastating bacterial canker of tomato [153]. Strain UFB2 has a broadspectrum antimicrobial activity against common soil-borne pathogens, including both
plant pathogenic fungi and pathogenic bacteria. Plate assays showed that strain UFB2
was especially efficient in inhibiting the growth of Clavibacter michiganensis subsp.
michiganensis. Green house trials showed that strain UFB2 can be used for disease
control efficacy against bacterial canker of tomato.
Materials and Methods
Bacterial strains, plasmids and culture medium
Bacterial strains and plasmids used in this study are listed in Table 4.1.
Escherichia coli strain TransforMaxTM EC100DTM pir+ (Epicentre Biotechnologies,
Madison, WI, USA) was used for plasmid rescue cloning and cultured in Luria-Bertani
(LB) medium at 37oC. Nutrient broth–yeast extract (NBY) agar medium [37] was used to
culture P. chlororaphis Strain UFB2 and for plate bioassays of the antimicrobial
activities evaluation. Potato dextrose agar (PDA, Difco, Detroit, MI) was used for plate
bioassays to evaluate antifungal activities. Kanamycin (Sigma Chemical Co., St. Louis,
MO), if applicable, were added to media as 100mg/mL for UFB2 mutants.

81

Bioassay for antimicrobial activities
P. chlororaphis strain UFB2 and its mutants used in this study were evaluated for
antimicrobial activities against plant pathogenic fungi and bacteria (Table 4.2) using PDA
or NBY plate bioassays. The bioassay procedure was similar to that described by ScholzSchroeder and colleagues [118]. Briefly, UFB2 and mutants were grown overnight in 5
ml of NBY liquid medium at 28oC. Bacterial cells were collected by centrifugation and
resuspended in sterile distilled water (SDW) to an optical density of 0.3 at OD420
(approximately 2 ×108 CFU/ml). 5-µl aliquots of bacterial suspension were inoculated
onto the center of NBY or PDA plates. After the plates were incubated for 3 days at
28°C, the agar plates were oversprayed with suspension of indicator pathogenic bacteria
(OD420=0.3), PDA plates were oversprayed with the indicator fungus (OD420=0.3) or
inoculated with indicator-growing agar. Inhibition zones were measured from the
margins of bacterial colonies 24 hours later and the size of the zone were compared
between UFB2 and mutants. Three replicates for the plate bioassays were performed
independently and standard deviations of means were calculated.
Random mutagenesis
EZ-Tn5 <R6Kcori/KAN-2>Tnp Transposome kit was used as recommended by
manufacturer (Epicentre Biotechnologies, Madison, WI) to characterize the genes
dedicated to antibacterial activity of UFB2. Competent cells of strain UFB2 were
prepared for electroporation as described previously [117]. UFB2 colonies growing on
the NBY plates supplemented with 100 µg ml-1 kanamycin were selected for plate
bioassays. The mutants that exhibited reduced or no antibacterial activity against Erwinia
amylovora and Geotrichum candidum were used for further studies. 16S rRNA and RecA
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genes were cloned and sequenced to confirm that the resulting mutants were derivatives
of strain UFB2. Plasmid rescue cloning was performed according to the transposome kit
instructions. To confirm that the rescue plasmid contained the transposon sequence, a
portion of the Tn5 transposon sequence was amplified by PCR with the primers R6kF1
(5’- GGGTAGCCAGCAGCATCCT-3’) and R6kR1 (5’- CATGATCGTGCTC
CTGTCGTT-3’). The positive rescue clones were sequenced for further analysis.
Sequence analysis was accomplished using the Lasergene Cloning suite version 12
(DNASTAR, Inc., Madison, WI). DNA sequences of the disrupted genes were searched
against the non-redundant database by BLASTx search.
Greenhouse trials
Greenhouse trials to evaluate control efficacy of strain UFB2 as a preventative
agent were conducted as performed by Ingram and Lu [170]. Tomato (Better Boy variety)
foliage was sprayed weekly beginning just before the growth runoff [211] with UFB2
cells at OD420 0.3, cell-free extract of UFB2, MT21624 and MT30636 prepared by
filtering the liquid growth medium to remove cells, water and control antibiotic
(streptomycin) at the recommended rate for plant disease management. Plants were
grown in 2-gal plastic pots with top planting soil in north farm MSU, or 7-gal plastic bags
in Truck Crops Branch Experiment Station in Crystal Springs, MS, respectively. The
plants at the first flowering and fruit set were sprayed with the bacterial suspensions and
extracts. The bacterial canker pathogen Clavibacter michiganensis subsp. michiganensis
1-07 was spray inoculated on the foliage one hour later. The preventative spray
treatments were performed weekly for four weeks as described by Ingram and Lu [170].
There were 24 plants for each treatment and controls. All experiments were repeated for
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three times. The disease visual rating was determined weekly for six weeks. Disease
severity was rated as described previously [170]. The experiments were repeated three
times independently.
Results
Antimicrobial activity of strain UFB2
Plate assays of strain UFB2 demonstrated significant antimicrobial activity
against a broad array of plant bacterial and fungal pathogens (Figure 4.1 and Table 4.2).
The result showed that strain UFB2 could most significantly inhibit the gram-positive
bacteria Clavibacter michiganensis subsp. michiganensis, the pathogen of tomato
bacterial canker disease [137]. UFB2 was also effective in inhibiting bacterial pathogen
Erwinia amylovora, that could cause fire blight diseases on apple and pears [136].
Strain UFB2 also showed an overall great inhibitory activities to a wide range of
plant pathogenic fungi, including Geotrichum candidum that could cause sour rot of
citrus fruits, tomatoes, carrot and some vegetables [212], corn northern blight pathogen
Cochliobolus heterostrophus, apple bit rot pathogen Glomerella cingulate [213-215],
take all pathogen Gaeumannomyces graminis [216], Aspergillus flavus which is a
devastating pathogen on cereal grains, legumes, and tree nuts [217-219], and
Thielaviopsis basicola that causes black root rot on tobacco and ornamentals [220]. In
addition, the wood-decay fungi Tyromyces chioneus and Cladosporium sp.were also
significantly inhibited by strain UFB2. The overall UFB2 antimicrobial test result
indicated that strain UFB2 have great potential as a broad spectrum biocontrol agent
against plant pathogens.
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Two mutants of strain UFB2, MT21624 and MT30636, were obtained using
transposon system (EZ-Tn5 <R6Kγori/KAN-2>Tnp Transposome, Epicentre
Technologies, Madison, WI). The mutants had significantly decreased antibacterial
activity against Clavibacter michiganensis subsp. michiganensis (Figure 4.2) and Erwinia
amylovora (Figure 4.3). The antifungal activities of MT21624 and MT30636 were also
measured by using the indicator fungi Geotrichum candidum (Figure 4.3) and other
pathogenic fungi. Both of the mutants showed decreased antifungal activities compared
to the wild type strain UFB2. The results of antimicrobial activity assay are shown in
table 4.2.
Identification of genes involved in production of the antibacterial product
Plasmid rescue method was applied to research the disrupted genes in the
mutants. BLAST analysis using the DNA sequence generated from the plasmid p21624
rescued from the mutant MT21624 against the UFB2 genome showed that the disrupted
gene VM99_RS23970 is 609 bp in size that shared a 99% identity with a transcriptional
regulatory gene phlF in antibiotic 2,4-Diacetylphloroglucinol (2,4-DAPG) biosynthetic
cluster of Pseudomonas fluorescens Q2-87 [221]; The disrupted gene VM99_RS23990 in
mutant MT30636 is 1,050 bp in size, encoding a 349-aa peptide and the deduced peptide
shared a 99% identity with a type III polyketide synthase gene phlD of Pseudomonas
fluorescens Q2-87.
The disrupted genes in the two mutants are within a gene cluster, according to the
nucleotide BLAST and amino acid sequence analysis, the gene cluster in UFB2 genome
shared an 98% similarity with the antibiotic 2,4-DAPG biosynthetic gene cluster that first
identified from Pseudomonas fluorescens Q2-87. By disrupting either of the regulatory
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gene or biosynthesis gene in the 2,4-DAPG biosynthetic gene cluster, the UFB2 mutants
showed a complete or significant loss of the antimicrobial activity. As a result, 2,4-DAPG
was considered to largely contribute to strain UFB2 antimicrobial activities.
Strain UFB2 as a disease-preventative agent on tomato
Clavibacter michiganensis subsp. michiganensis 1-07 was initially spray
inoculated on the tomato foliage. Then five different spray treatments were conducted
once a week for four weeks. The five spray treatments include water (as negative
control), UFB2 living cell phosphate buffer suspension, UFB2 cell-free extract,
MT21624 cell-free extract, MT30636 cell-free extract and antibiotic (streptomycin).
Disease symptoms such as canker lesions, leaf wilting and leaf spotting became visible
four weeks after the inoculation. Leaf necrosis developed more quickly in water-treated
tomato than any other treatment after four weeks. The severely damaged plants in the
water treatment exhibited distorted growth and fruit drop, and the symptoms spread to the
whole plant by the sixth week. Similar symptoms were observed on MT21624 and
MT30636 cell-free extract treatment groups. The tomato plants in UFB2 cell treatment
showed overall less severe symptoms compared to those in water or UFB2 mutants cellfree extract treatment. Tomato plants in UFB2 cell-free extract treatment and the
antibiotic treatment showed best disease management results by having much less
symptom and much slow disease development till the end of disease rating at week 6
(Figure 4.5) after the treatment spray stopped at week 4. According to the disease visual
rating data (Figure 4.6), the plants that received the UFB2 cell-free extract and
streptomycin treatments showed significantly reduced disease severity by having only
less than 15% affected plants as compared to the other treatment groups, which generally
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have 30%-45% of total plants infected and showing obvious symptom. The green house
trail data indicate the disease control efficacy of UFB2 cell-free culture extract was no
significant difference (p<0.05) with that of streptomycin at the recommended rate for
plant disease management.
Discussion
UFB2 has a wide spectrum of antimicrobial activity. We used two plantpathogenic bacterial indicators and eight plant-pathogenic fungal indicators in the test.
The results showed UFB2 has significant antimicrobial activities. The Tn5 transposome
mutagenesis and complementation results demonstrated that 2,4-DAPG biosynthetic gene
cluster (phl) may be directly related and required for UFB2 antimicrobial activities. The
phl gene cluster product had been reported to be an effective antibiotic against common
plant diseases. However, the antibacterial activity against tomato pathogen Clavibacter
michiganensis subsp. michiganensis is firstly reported of the species Pseudomonas
chlororaphis.
The green house trails confirmed both the 2,4-DAPG as the main contributor of
UFB2 antibacterial activities and the great efficiency of UFB2 cell-free extract as a
preventative agent to protect tomato plant from the pathogen. The trails results showed
that disease control efficacy of living cells of UFB2 was not good as that of the culture
extract of the bacteria. It may be resulted from poor growth and production of the
antibacterial compound of the strain UFB2 because this bacterium was isolated from soil.
More research activities are needed to investigate biology and formulation of strain UFB2
as a biological control agent. Nevertheless, strain UFB2 has a great potential as a
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biocontrol agent against the tomato bacterial canker pathogen Clavibacter michiganensis
subsp. michiganensis.
Conclusion
This study reveals strain UFB2 has a significant antimicrobial activities against
various plant pathogens, especially tomato bacterial canker pathogen. Mutagenesis and
bioassays demonstrate that a 2,4-DAPG biosynthetic gene cluster contributes to the
biosynthesis of the antimicrobial compound. Green house trail indicated strain UFB2
cell-free extract could be used to control bacterial canker disease of tomato caused by
Clavibacter michiganensis subsp. michiganensis as a preventative spray agent. This work
will provide important clues for development of strain UFB2 as a potential biocontrol
agent for agricultural application.
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Table 4.1

Bacterial strains and plasmids

Strains or
Relevant characteristics
plasmids
Escherichia coli
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80dlacZΔM15 ΔlacX74 recA1 endA1
Ec100D
araD139 Δ(ara, leu)7697 galU galK λ- rpsL (StrR) nupG pir+(DHFR)
Pseudomonas chlororaphis
UFB2
Wild-type strain
Transcriptional regulatory gene VM99_RS23970::Tn5 derivative of
MT21624
UFB2; Kmr
MT30636
Type III PKS phlD gene VM99_RS23990::Tn5 derivative of UFB2; Kmr
Plasmids
P21624
EZ-Tn5 carrying 0.7-kb genomic DNA of MT21624; Kmr
P30636
EZ-Tn5 carrying 1.1-kb genomic DNA of MT30636; Kmr

Kmr stands for kanamycin resistance.
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Source
reference

or

Epicentre
Corporation

This study
This study
This study
This study

Table 4.2

Antimicrobial activities of P. chlororaphis strain UFB2, MT21624 and
MT30636
Inhibition Zone Radius (mm)

Indicator Pathogenic Bacteria and Fungi

UFB2

MT20624

MT30636

Escherichia coli Ec101

16±1.01

0

0

Clavibacter michiganesis subsp. michiganesis 1-07

28±0.218

0

7±0.774

Erwinia amylovora 2029

25±1.060

0

11±0.450

Burkholderia glumae 291

23±1.004

22±0.699

22±1.561

Ralstonia solanacearum MS444

21±2.041

11±1.501

15±1.284

Xanthomonas citri pv. malvacearum MSCT1

21±1.106

0

12±1.152

2±1.066

13±0.443

Pectobacterium carotovorum sub carotovoro EC101 15±1.474
Pseudomonas syringae B301D

0

0

10±0.800

Bacillus megaterium Km

15±1.051

13±0.602

13±0.504

Geotrichum candidum

17±0.775

0

10±0.072

Aspergillus flavus

16±0.028

0

12±0.028

Gaeumannomyces graminis

20±0.743

0

7±0.349

Cladosporium sp.

13±0.544

0

11±0.091

Glomerella cingulata

18±0.053

0

8±0.276

Cochliobolus heterostrophus

23±0.060

0

7±0.068

Tyromyces chioneus

20±0.118

0

6±0.091
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Figure 4.1

Antimicrobial ability of P. chlororaphis strain UFB2 against common plant
pathogens.

A: Erwinia amylovora, B: Clavibacter michiganensis subsp. michiganensis, C:
Tyromyces chioneus 169B, D: Geotrichum candidum, E: Cochliobolus heterostrophus, F:
Cladosporium sp., G: Glomerella cingulate, H: Gaeumannomyces graminis, I:
Aspergillus flavus, J: Thielaviopsis basicola.

Figure 4.2

Antimicrobial ability of P. chlororaphis strain UFB2, MT21624 and
MT30636 against Clavibacter michiganensis subsp. michiganensis.
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Figure 4.3

Antimicrobial ability of P. chlororaphis strain UFB2, MT21624 and
MT30636 against Geotrichum candidum (A) and Erwinia amylovora (B).

Figure 4.4

A 10 Kb genomic region of P. chlororaphis strain UFB2 containing
complete 2,4-DAPG biosynthetic gene cluster.
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Figure 4.5

Green house trail of P. chlororaphis strain UFB2 in controlling bacterial
canker disease of tomato.

Green house tomato six weeks after inoculation with Cmm. Symptoms on (1) water
treatment, (2) P. chlororaphis strain UFB2 cell suspension treatment, (3) MT21624 cellfree extract, (4) MT30636 cell-free extract, (5) P. chlororaphis strain UFB2 cell-free
extract treatment and (6) streptomycin treatment.
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Figure 4.6

The disease rating of greenhouse tomato treated by P. chlororaphis strain
UFB2 cells, UFB2 cell-free extract, MT21624 cell-free extract, MT30636
cell-free extract, water and antibiotic (streptomycin).
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